<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_ajGMuyH">Impact of Bifrontal Home-Based Transcranial Direct Current Stimulation in Pain Catastrophizing and Disability due to Pain in Fibromyalgia: A Randomized, Double-Blind Sham-Controlled Study</title>
				<funder>
					<orgName type="full">Brazilian</orgName>
				</funder>
				<funder>
					<orgName type="full">CFSA</orgName>
				</funder>
				<funder ref="#_6cKqN7m">
					<orgName type="full">Foundation for the Support of Research at Rio Grande do Sul (FAPERGS) Ministry of Science and Technology.National Council for Scientific and Technological Development -(CNPq)/ Health Secretary of state of Rio Grande do Sul, Brazil</orgName>
				</funder>
				<funder ref="#_pNTX4yH">
					<orgName type="full">Development of Higher Education Personnel-CAPES PNPD</orgName>
				</funder>
				<funder ref="#_HtCNh3p">
					<orgName type="full">Postgraduate Research Group</orgName>
				</funder>
				<funder ref="#_np8xP88">
					<orgName type="full">National Council for Scientific and Technological Development -CNPq</orgName>
				</funder>
				<funder>
					<orgName type="full">Hospital de Cl ınicas de Porto Alegre</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Wolnei</forename><surname>Caumo</surname></persName>
							<email>wcaumo@hcpa.edu</email>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>y</label> Post-Graduate Program in Medical Sciences , School of Medicine , Universidade Federal do Rio Grande do Sul (UFRGS) , Porto Alegre , Brazil , Laboratory of Pain and Neuromodulation at Hospital de Cl ınicas de Porto Alegre (HCPA) , Porto Alegre , Brazil ,</note>
								<orgName type="department" key="dep1">Post-Graduate Program in Medical Sciences</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="laboratory">Laboratory of Pain and Neuromodulation at Hospital de Cl ınicas de Porto Alegre (HCPA)</orgName>
								<orgName type="institution">Universidade Federal do Rio Grande do Sul (UFRGS)</orgName>
								<address>
									<settlement>Porto Alegre Porto Alegre</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>{</label> Pain and Palliative Care Service at HCPA , Brazil ,</note>
								<orgName type="department">Pain and Palliative Care Service at HCPA</orgName>
								<address>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>k</label> Department of Surgery , School of Medicine , UFRGS , Brazil ,</note>
								<orgName type="department" key="dep1">Department of Surgery</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="institution">UFRGS</orgName>
								<address>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>*</label> Laboratorio de Farmacologia da Dor e Neuromodulaç ão: Investigacoes Pre-clinicas , Centro de Pesquisa Experimental (CPE) , Hospital de Cl ınicas de Porto Alegre (HCPA) , Porto Alegre , Brazil</note>
								<orgName type="department">Centro de Pesquisa Experimental (CPE)</orgName>
								<orgName type="laboratory">Laboratorio de Farmacologia da Dor e Neuromodulaç ão: Investigacoes Pre-clinicas</orgName>
								<orgName type="institution">Hospital de Cl ınicas de Porto Alegre (HCPA)</orgName>
								<address>
									<settlement>Porto Alegre</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rael</forename><forename type="middle">Lopes</forename><surname>Alves</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>y</label> Post-Graduate Program in Medical Sciences , School of Medicine , Universidade Federal do Rio Grande do Sul (UFRGS) , Porto Alegre , Brazil , Laboratory of Pain and Neuromodulation at Hospital de Cl ınicas de Porto Alegre (HCPA) , Porto Alegre , Brazil ,</note>
								<orgName type="department" key="dep1">Post-Graduate Program in Medical Sciences</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="laboratory">Laboratory of Pain and Neuromodulation at Hospital de Cl ınicas de Porto Alegre (HCPA)</orgName>
								<orgName type="institution">Universidade Federal do Rio Grande do Sul (UFRGS)</orgName>
								<address>
									<settlement>Porto Alegre Porto Alegre</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>*</label> Laboratorio de Farmacologia da Dor e Neuromodulaç ão: Investigacoes Pre-clinicas , Centro de Pesquisa Experimental (CPE) , Hospital de Cl ınicas de Porto Alegre (HCPA) , Porto Alegre , Brazil</note>
								<orgName type="department">Centro de Pesquisa Experimental (CPE)</orgName>
								<orgName type="laboratory">Laboratorio de Farmacologia da Dor e Neuromodulaç ão: Investigacoes Pre-clinicas</orgName>
								<orgName type="institution">Hospital de Cl ınicas de Porto Alegre (HCPA)</orgName>
								<address>
									<settlement>Porto Alegre</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Paul</forename><surname>Vicu</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>y</label> Post-Graduate Program in Medical Sciences , School of Medicine , Universidade Federal do Rio Grande do Sul (UFRGS) , Porto Alegre , Brazil , Laboratory of Pain and Neuromodulation at Hospital de Cl ınicas de Porto Alegre (HCPA) , Porto Alegre , Brazil ,</note>
								<orgName type="department" key="dep1">Post-Graduate Program in Medical Sciences</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="laboratory">Laboratory of Pain and Neuromodulation at Hospital de Cl ınicas de Porto Alegre (HCPA)</orgName>
								<orgName type="institution">Universidade Federal do Rio Grande do Sul (UFRGS)</orgName>
								<address>
									<settlement>Porto Alegre Porto Alegre</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>*</label> Laboratorio de Farmacologia da Dor e Neuromodulaç ão: Investigacoes Pre-clinicas , Centro de Pesquisa Experimental (CPE) , Hospital de Cl ınicas de Porto Alegre (HCPA) , Porto Alegre , Brazil</note>
								<orgName type="department">Centro de Pesquisa Experimental (CPE)</orgName>
								<orgName type="laboratory">Laboratorio de Farmacologia da Dor e Neuromodulaç ão: Investigacoes Pre-clinicas</orgName>
								<orgName type="institution">Hospital de Cl ınicas de Porto Alegre (HCPA)</orgName>
								<address>
									<settlement>Porto Alegre</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Camila</forename><surname>Fernanda</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Silveira</forename><surname>Alves</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>y</label> Post-Graduate Program in Medical Sciences , School of Medicine , Universidade Federal do Rio Grande do Sul (UFRGS) , Porto Alegre , Brazil , Laboratory of Pain and Neuromodulation at Hospital de Cl ınicas de Porto Alegre (HCPA) , Porto Alegre , Brazil ,</note>
								<orgName type="department" key="dep1">Post-Graduate Program in Medical Sciences</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="laboratory">Laboratory of Pain and Neuromodulation at Hospital de Cl ınicas de Porto Alegre (HCPA)</orgName>
								<orgName type="institution">Universidade Federal do Rio Grande do Sul (UFRGS)</orgName>
								<address>
									<settlement>Porto Alegre Porto Alegre</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>*</label> Laboratorio de Farmacologia da Dor e Neuromodulaç ão: Investigacoes Pre-clinicas , Centro de Pesquisa Experimental (CPE) , Hospital de Cl ınicas de Porto Alegre (HCPA) , Porto Alegre , Brazil</note>
								<orgName type="department">Centro de Pesquisa Experimental (CPE)</orgName>
								<orgName type="laboratory">Laboratorio de Farmacologia da Dor e Neuromodulaç ão: Investigacoes Pre-clinicas</orgName>
								<orgName type="institution">Hospital de Cl ınicas de Porto Alegre (HCPA)</orgName>
								<address>
									<settlement>Porto Alegre</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Leticia</forename><surname>Ramalho</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>y</label> Post-Graduate Program in Medical Sciences , School of Medicine , Universidade Federal do Rio Grande do Sul (UFRGS) , Porto Alegre , Brazil , Laboratory of Pain and Neuromodulation at Hospital de Cl ınicas de Porto Alegre (HCPA) , Porto Alegre , Brazil ,</note>
								<orgName type="department" key="dep1">Post-Graduate Program in Medical Sciences</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="laboratory">Laboratory of Pain and Neuromodulation at Hospital de Cl ınicas de Porto Alegre (HCPA)</orgName>
								<orgName type="institution">Universidade Federal do Rio Grande do Sul (UFRGS)</orgName>
								<address>
									<settlement>Porto Alegre Porto Alegre</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>*</label> Laboratorio de Farmacologia da Dor e Neuromodulaç ão: Investigacoes Pre-clinicas , Centro de Pesquisa Experimental (CPE) , Hospital de Cl ınicas de Porto Alegre (HCPA) , Porto Alegre , Brazil</note>
								<orgName type="department">Centro de Pesquisa Experimental (CPE)</orgName>
								<orgName type="laboratory">Laboratorio de Farmacologia da Dor e Neuromodulaç ão: Investigacoes Pre-clinicas</orgName>
								<orgName type="institution">Hospital de Cl ınicas de Porto Alegre (HCPA)</orgName>
								<address>
									<settlement>Porto Alegre</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Paulo</forename><forename type="middle">R S</forename><surname>Sanches</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>z</label> Laboratory of Biomedical Engineer at HCPA , Porto Alegre , Brazil ,</note>
								<orgName type="laboratory">Laboratory of Biomedical Engineer at HCPA</orgName>
								<address>
									<settlement>Porto Alegre</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Danton</forename><forename type="middle">P</forename><surname>Silva</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>z</label> Laboratory of Biomedical Engineer at HCPA , Porto Alegre , Brazil ,</note>
								<orgName type="laboratory">Laboratory of Biomedical Engineer at HCPA</orgName>
								<address>
									<settlement>Porto Alegre</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Iraci</forename><surname>Lucena Da</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Silva</forename><surname>Torres</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Felipe</forename><surname>Fregni</surname></persName>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>x</label> Laboratory of Neuromodulation and Center for Clinical Research Learning , Physics and Rehabilitation Department , Spaulding Rehabilitation Hospital , Boston , Massachusetts ,</note>
								<orgName type="department">Physics and Rehabilitation Department</orgName>
								<orgName type="laboratory">Laboratory of Neuromodulation and Center for Clinical Research Learning</orgName>
								<orgName type="institution">Spaulding Rehabilitation Hospital</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>*</label> Laboratorio de Farmacologia da Dor e Neuromodulaç ão: Investigacoes Pre-clinicas , Centro de Pesquisa Experimental (CPE) , Hospital de Cl ınicas de Porto Alegre (HCPA) , Porto Alegre , Brazil</note>
								<orgName type="department">Centro de Pesquisa Experimental (CPE)</orgName>
								<orgName type="laboratory">Laboratorio de Farmacologia da Dor e Neuromodulaç ão: Investigacoes Pre-clinicas</orgName>
								<orgName type="institution">Hospital de Cl ınicas de Porto Alegre (HCPA)</orgName>
								<address>
									<settlement>Porto Alegre</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<note type="raw_affiliation">Labo- ratory of Pain and Neuromodulation ; Institution: Hospital de Cl ınicas de Porto Alegre at UFRGS. Ramiro Barcelos , 2350 - CEP 90035-003 Bairro Rio Branco -Porto Alegre -Rio Grande do Sul , Brazil.</note>
								<orgName type="department" key="dep1">Labo- ratory of Pain and Neuromodulation</orgName>
								<orgName type="department" key="dep2">Institution: Hospital de Cl ınicas</orgName>
								<orgName type="institution">de Porto Alegre at UFRGS. Ramiro Barcelos</orgName>
								<address>
									<addrLine>CEP</addrLine>
									<postCode>2350 - 90035-003</postCode>
									<settlement>Bairro Rio Branco -Porto Alegre -Rio Grande do Sul</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_u96y29z">Impact of Bifrontal Home-Based Transcranial Direct Current Stimulation in Pain Catastrophizing and Disability due to Pain in Fibromyalgia: A Randomized, Double-Blind Sham-Controlled Study</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">F364A00F3D5C4187092F24E1799AA4EF</idno>
					<idno type="DOI">10.1016/j.jpain.2021.11.002</idno>
					<note type="submission">Received April 10, 2021; Revised September 5, 2021; Accepted November 8, 2021.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T06:02+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_6VY4Vua">Fibromyalgia</term>
					<term xml:id="_P77Tpe6">pain</term>
					<term xml:id="_aSygS6u">home-based tDCS</term>
					<term xml:id="_CGjphgF">disability</term>
					<term xml:id="_aYfRKSc">catastrophizing</term>
					<term xml:id="_JTQ865X">BDNF</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_pKjkHvG"><p xml:id="_HaUVHBF"><s xml:id="_gjDrVgt">This randomized, double-blind trial tested the hypothesis that 20 sessions of home-based anodal(a)-transcranial direct current stimulation (tDCS) (2mA for 20 minutes) bifrontal, with anodal on the left dorsolateral prefrontal cortex (l-DLPFC) would be better than sham-(s)-tDCS to reduce scores on Pain Catastrophizing Scale and disability-related to pain assessed by the Profile of Chronic Pain: Screen (primary outcomes).</s><s xml:id="_eEjPWUc">Secondary outcomes were depressive symptoms, sleep quality, heat pain threshold , heat pain tolerance , and serum brain-derived-neurotrophic-factor (BDNF).</s><s xml:id="_K65qPTQ">Fortyeight women with fibromyalgia, 30 to 65 years-old were randomized into 2:1 groups [a-tDCS (n = 32) or s-tDCS (n = 16)].</s><s xml:id="_rge7aXs">Post hoc analysis revealed that a-tDCS reduced the Pain Catastrophizing Scale total scores by 51.38% compared to 26.96% in s-tDCS, and a-tDCS reduced Profile of Chronic Pain: Screen total scores by 31.43% compared to 19.15% in s-tDCS.</s><s xml:id="_qB3xQtW">The a-tDCS improved depressive symptoms, sleep quality and increased the heat pain tolerance.</s><s xml:id="_Bm4zq28">The delta-value in the serum BDNF (mean post treatment end minus pretreatment) was conversely correlated with the a-tDCS effect in pain catastrophizing.</s><s xml:id="_2kxgnMF">In contrast, the a-tDCS impact on reducing the disability-related to pain at the treatment end was positively associated with a reduction in the serum BDNF and improvement of depressive symptoms, sleep quality and pain catastrophizing symptoms.</s></p><p xml:id="_KzUVZ8s"><s xml:id="_E5c7qPh">Perspective: Home-based bifrontal tDCS with a-tDCS on the l-DLPFC are associated with a moderate effect size (ES) in the following outcomes: 1) Decreased rumination and magnification of pain</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="593.858" lry="792.0"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="593.858" lry="792.0"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="593.858" lry="792.0"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="593.858" lry="792.0"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="593.858" lry="792.0"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="593.858" lry="792.0"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="593.858" lry="792.0"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="593.858" lry="792.0"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="593.858" lry="792.0"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="593.858" lry="792.0"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="792.0" lry="593.858"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="593.858" lry="792.0"/>
		<surface n="13" ulx="0.0" uly="0.0" lrx="593.858" lry="792.0"/>
		<surface n="14" ulx="0.0" uly="0.0" lrx="593.858" lry="792.0"/>
		<surface n="15" ulx="0.0" uly="0.0" lrx="593.858" lry="792.0"/>
		<surface n="16" ulx="0.0" uly="0.0" lrx="593.858" lry="792.0"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_E7Ty6Z9">F</head><p xml:id="_VyDUqQz"><s xml:id="_3Pn2AEv">ibromyalgia is a chronic primary pain condition defined as diffuse pain associated with significant emotional distress related to functional disability. <ref type="bibr" target="#b43">44</ref></s><s xml:id="_QHzbFQA">It encompasses widespread pain and a persistent state of high reactivity that amplifies nociceptive stimuli. <ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b31">32,</ref><ref type="bibr" target="#b65">66</ref></s><s xml:id="_5uJM6aQ">Additional symptoms include fatigue, depressive symptoms, cognitive problems, sleep disturbances, and multisensory hypersensitivity. <ref type="bibr" target="#b28">29</ref></s><s xml:id="_mHbCjE2">Such dysfunctional symptoms might be aggravated in chronic pain, including somatization, helplessness, and catastrophizing. <ref type="bibr" target="#b65">66</ref></s><s xml:id="_6Snah6y">Pain catastrophizing is a maladaptive emotional and cognitive response to pain characterized by a propensity to ruminate about it, magnify the threat associated with it, and feel helpless in the face of pain. <ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b59">60</ref></s><s xml:id="_en9crVu">According to a neurofunctional imaging study, pain catastrophizing is related to greater activity in the dorsolateral prefrontal cortex (DLPFC). <ref type="bibr" target="#b20">21</ref></s><s xml:id="_78YNM2x">ncreased bilateral activation of prefrontal cortex (PFC), particularly the left-(l)-DLPFC, has been correlated with pain inhibition in healthy subjects experiencing prolonged acute pain stimulation. <ref type="bibr" target="#b36">37</ref></s><s xml:id="_CTf4Fea">In contrast, perceived control of pain was associated with activating the right-(r)-DLPFC. <ref type="bibr" target="#b1">2</ref></s><s xml:id="_CCqKxEK">While one functional neuroimage study in depressive disorders, found that hopelessness and negative emotional judgment are related to PFC left-right imbalance with a more pronounced hypoactivation in the left. <ref type="bibr" target="#b25">26</ref></s><s xml:id="_jBAugzS">Hence, activation and deactivation of neural circuits in PFC might be related to maladaptive pain processes, where GABAergic neurons modulate neuronal activity.</s><s xml:id="_TAZf5Bq">These circuits are also involved in pain's sensory, cognitive, and affective components.</s><s xml:id="_gCktV4H">They participate in fine-tuning the balance between descending facilitation and descending inhibition of nociception via the periaqueductal gray and rostral ventral medulla -oblongata-spinal-cord axis. <ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b49">50</ref></s><s xml:id="_pezSf6R">Thus, transcranial direct current stimulation (tDCS) is a promising therapeutic option to improve the inter-hemispheric balance, either when applied to the primary motor cortex or the DLPFC. <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b60">61</ref></s><s xml:id="_QyNn2Sv">However, the l-DLPFC offers a potential advantage to modulate neural networks on the interface between cognitive processing and pain regulation.</s></p><p xml:id="_4uKcaAn"><s xml:id="_yNYhnTh">The impact of anodal-(a)-tDCS on clinical symptoms depends on the cortical area of stimulation and polarity of the current. <ref type="bibr" target="#b67">68</ref></s><s xml:id="_uGYKH7j">Anodal stimulation generally augments neuronal excitability, whereas cathodal stimulation produces the opposite effect. <ref type="bibr" target="#b37">38</ref></s><s xml:id="_ywxUwGv">tDCS modulates both gene and protein expression of brain derivate neurotrophic factors (BDNF). <ref type="bibr" target="#b19">20</ref></s><s xml:id="_vcTENeE">In fibromyalgia, higher levels of BDNF have been associated with greater disinhibition in the descending pain inhibitory system <ref type="bibr" target="#b57">58</ref> and with a lower pain pressure threshold. <ref type="bibr" target="#b66">67</ref></s><s xml:id="_2NXbtBz">Although the serum BDNF is a surrogate marker of neuroplasticity state, which might predict reducing pain score, <ref type="bibr" target="#b7">8</ref> the results after tDCS in BDNF are mixed.</s><s xml:id="_R7ytxwG">So, it is impossible to disentangle tDCS effects from time effects and if they occur in specific pathways or are necessary to induce a clinical response. <ref type="bibr" target="#b9">10</ref></s><s xml:id="_kujA7vx">n healthy volunteers the a-tDCS on l-DLPFC increased pain tolerance <ref type="bibr" target="#b37">38</ref> and reduced the valence for negative emotional images. <ref type="bibr" target="#b45">46,</ref><ref type="bibr" target="#b46">47</ref></s><s xml:id="_7Db97Vx">Also, it modulated pain correlates such as anxiety, depressive symptoms, and unpleasant sensation to a painful stimulus. <ref type="bibr" target="#b44">45</ref></s><s xml:id="_RYwAPaz">In fibromyalgia the a-tDCS on the l-DLPFC reduced pain, <ref type="bibr" target="#b7">8</ref> improved cognitive performance, <ref type="bibr" target="#b41">42,</ref><ref type="bibr" target="#b51">52</ref> and increased heat pain threshold (HPT). <ref type="bibr" target="#b51">52,</ref><ref type="bibr" target="#b56">57</ref></s><s xml:id="_WHgrDMT">Although the initial data suggest its possible benefits on emotional aspects associated with pain, there is a gap in the literature related to the impact of a-tDCS bifrontal selfadministered at home linked to pain catastrophizing and disability-related to pain (DRP) for daily activities.</s><s xml:id="_RvtcjwK">Thus, our purpose was to test the hypothesis that 20 sessions of anodal-(a)-DCS on the l-DLPFC and cathodal on the right (r)-DLPFC over 4 weeks would be better than a sham-(s)-tDCS to reduce the total scores on Pain Catastrophizing Scale (PCS) and DRP assessed by the Profile of Chronic Pain: Screen (PCP: S) (primary outcomes).</s><s xml:id="_FPbhwU2">Secondary outcomes were PCSdomains (rumination, magnification, and helplessness), PCP:S domains (severity, disability for daily activities and emotional], depressive symptoms, sleep quality, serum BDNF, HPT, and heat pain tolerance (HPTo).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_8ja6Hpu">Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ZWQBCJ5">Study Design and Eligibility</head><p xml:id="_3auyN5u"><s xml:id="_ZQQummC">The Research Ethics Committee approved the protocol for this trial at the Hospital de Cl ınicas de Porto Alegre (HCPA), Brazil.</s><s xml:id="_qA5ZQa5">Institutional Review Board IRB (CAAE 2018-0353).</s><s xml:id="_Q7K7YRZ">Before participating in this randomized, double-blind, sham-controlled trial, all patients provided oral and written informed consent.</s><s xml:id="_MjhfeZR">Participants did not receive payment in exchange for their participation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_sJygZsu">Inclusion and Exclusion Criteria</head><p xml:id="_a7RcBFs"><s xml:id="_R95YhQz">We included 48 right-handed adult females aged 30 to 65 years.</s><s xml:id="_Mj7xdM9">All included subjects met diagnostic criteria for the Diagnosis of Fibromyalgia by the standard assessment protocol criteria according to "American College of Rheumatology (ACR) -2016).</s><s xml:id="_2dKjv7Y">A Brazilian Board-Certified pain physician evaluated patients according to the eligibility criteria.</s><s xml:id="_C3DUQe9">They were recruited from the outpatient pain clinic of the HCPA and via newspaper ads.</s><s xml:id="_Fcr9rJx">Volunteers were contacted by phone and invited for medical evaluation to confirm the diagnosis.</s><s xml:id="_Hm2NFX9">Subjects were included if they were able to read, and they would report a score of at least 6 on the Numerical Pain Scale (NPS 0-10) on most of the days of the last 3 months.</s><s xml:id="_fQNNX5M">Furthermore, they should have used the same doses of antidepressant and anticonvulsants drugs during the previous month before starting the study and agree to maintain these doses during the study period.</s></p><p xml:id="_PUXkMEP"><s xml:id="_jB4k5Ax">They were excluded if they had contraindications to use tDCS according to the recommended guidelines to use this technique, such as a history of brain surgery, tumor, stroke, or implantation of intracranial metal. <ref type="bibr" target="#b18">19</ref></s><s xml:id="_sJv95px">hey were also excluded if they had used illicit drugs in the last 6 months or a clinical disease uncompensated (ie, ischemic heart disease, renal disease, hepatic disease, etc.).</s><s xml:id="_BB6sxAH">Other exclusion criteria were a positive history of rheumatoid arthritis, lupus, auto-immune disease, neurologic or oncologic disease.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_XH88jhB">Sample Size Justification</head><p xml:id="_7YesyMN"><s xml:id="_xmZZQ3v">Sample size estimation was based on a previous study with a similar montage in patients with fibromyalgia. <ref type="bibr" target="#b7">8</ref></s><s xml:id="_dYuxBhj">his estimation was established using a 2-tailed hypothesis test for each of 2 primary outcomes (total scores in the catastrophizing pain scale PCS and total score in the disability due to pain scale [PCP:S]) for a randomized ratio into 2:1 to receive a-DLPFC versus s-DLPFC for type I error of 5% and a type II error 20%.</s><s xml:id="_RDaW8xB">The standard deviation (SD) used to estimate the effect size in each of the primary outcomes was the SD found in the s-tDCS in the previous study. <ref type="bibr" target="#b7">8</ref></s><s xml:id="_QA7sdpV">Considering that we used 20 tDCS sessions in this protocol, we based our estimate on half the effect size for the difference between treatment groups than observed in the previous study after 60 sessions of tDCS. <ref type="bibr" target="#b7">8</ref></s><s xml:id="_wYRvV4t">For an effect size (f) equal to .45 for treatment effect in the total score on PCS total by a standard deviation equal to 18.27, for this outcome, the estimated sample size was 42 subjects.</s><s xml:id="_YaVhmD9">For an effect size (f) equal to .5 for the treatment effect in the total score on PCP:S total by a standard deviation equal to 24.26, the estimated sample size was 34 subjects.</s><s xml:id="_FvuSuXY">To account that we have multiple outcomes, possible dropouts, and the possibility that the outcome measures would not be normally distributed, the final calculations included an increase of 12.5% in the total sample.</s><s xml:id="_SrHrBH4">Thus, the final sample size was 48 patients (32 in the a-tDCS vs 16 in the s-tDCS group).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_QnzVdzd">Randomization</head><p xml:id="_TAkEQyz"><s xml:id="_yYqBVun">Randomized numbers were generated using appropriate software to assign 48 patients at an allocation of 2:1 to groups a-tDCS or s-tDCS.</s><s xml:id="_Numh4nA">To avoid predicting the next patient, we used randomization in 6 blocks of 8. Before the recruitment phase, 2 investigators not involved in the patient's assessments made the randomization.</s><s xml:id="_uxrMfKx">They prepared the envelopes that contained the randomization number.</s><s xml:id="_Pv5EYqN">These envelopes were sealed, numbered sequentially, and they were opened after the participant consented to participate in the trial according to the numerical order registered outside.</s><s xml:id="_nbYNnNv">Who opened the envelopes and programmed the devices, was the engineer who was not involved with the clinical measures, subjects, or evaluators?</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_pWmDBM2">Blinding</head><p xml:id="_kmAUTrx"><s xml:id="_55yPgeM">During the entire protocol timeline of participants, all unaware of the treatment group, including research staff, investigators involved in patients' care, and those who applied the scales.</s><s xml:id="_n3jJWK8">According to the randomization code, 2 biomedical engineers (PRS.</s><s xml:id="_8TXAsef">and DPS) who were not involved in patients' assessment prepared the tDCS device to provide active or sham stimulation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_gWUXpDT">Intervention</head><p xml:id="_VkrpkvN"><s xml:id="_cgn9kYe">The scalp electrodes were positioned according to the 10 to 20 system for EEG (F3 anode, l-DLPFC) and the cathode at r-DLPFC (F4).</s><s xml:id="_KNJbFfS">The treatment was for 5 consecutive days, for 4 weeks.</s><s xml:id="_StJyC98">For the active tDCS, the current applied was 2mA for 20 minutes. <ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b10">11</ref></s><s xml:id="_46aFsf3">For sham conditions, the montage was the same as active tDCS.</s><s xml:id="_cfKPYyr">The ramp-up time of a-tDCS and s-tDCS stimulation was the 20 seconds for the current to go from 0 to 2 mA and a ramp-down time of 20 seconds.</s><s xml:id="_hKFGpKv">However, in the s-tDCS group, the device was programmed to offer 30 seconds of stimulation across the 20 minutes at the following time points: at the beginning, after 10 minutes, and 20 minutes.</s><s xml:id="_fPkJ5Fr">The device was programmed to automatically turn on and turn off at each one of these time points.</s><s xml:id="_bKQyNpD">We used this approach to blind the participant about the intervention they were receiving.</s><s xml:id="_YRQy5pV">The current was offered using 35 cm 2 electrodes coated with a vegetable sponge moistened with saline solution administered by 2 silicone cannulas coupled to the electrode.</s><s xml:id="_zBRRWsx">One biomedical engineer programmed the device to offer a fixed number of stimulation sessions, with a minimum interval between each consecutive session of 16 hours.</s></p><p xml:id="_vKs26dR"><s xml:id="_vS5vfPA">Treatment protocol with tDCS at home: visits to the center, size of the cap and electrodes' position, training session, protocol compliance, appropriate use, and record of adverse effects a. Visits of volunteers to the center in the course of the protocol Visit 1: They came to the center to give their written formal consent, confirm the diagnosis, answer the sociodemographic questionnaire and other measures of baseline assessment, and receive information about the protocol.</s></p><p xml:id="_E2Bce5c"><s xml:id="_ahQWfsD">Visit 2: They made a training session on how to use the device at home and received the first treatment session.</s></p><p xml:id="_WYTJQTk"><s xml:id="_H28KEp9">Visit 3: They came to the center after 4 weeks of tDCS at home when they did the assessment at treatment end and gave back the device.</s><s xml:id="_c2F59Ba">b.</s><s xml:id="_jM3ptdD">Procedures to choose the size of the cap and electrodes' position</s></p><p xml:id="_M69Qn77"><s xml:id="_njqAwFG">1) The researcher measures the head circumference, and he or she chose the size of the cap according.</s></p><p xml:id="_djYcHkH"><s xml:id="_gaSyZWC">There are 3 sizes of cap: small (38 cm x 55 cm), medium (39 cm x 57.5 cm), and large (40 cm x 59 cm).</s><s xml:id="_gNPZzHT">The cap has a Velcro strap attached to adjust the contact of the cap, ensuring the cap.</s><s xml:id="_yPz5cdg">The patients put the cap and check if the size cap could maintain sponges' contact with the scalp.</s><s xml:id="_bfdmVu3">The cap is to be neither tight nor loose but comfortable.</s></p><p xml:id="_wE6gSfw"><s xml:id="_ktNZ8k8">2) The participants put the cap on their heads, and the researcher measured to localize the positions of the electrodes according to the 10 to 20 system for EEG.</s></p><p xml:id="_KgsGdFQ"><s xml:id="_DEabEGZ">3) The researcher marked the region to fix the sponges on the F3 and F4 positions, according to the 10 to 20 system for EEG.</s><s xml:id="_gvfr44m">4) The electrodes from 35 cm 2 into were inserted on the vegetable sponges to deliver the current to the scalp.</s><s xml:id="_YnFCEQN">The electrodes were fixed inside the sponges so that the user cannot change the position and, thus, guarantee an accurate placement of the electrode to deliver the electric current during the stimulation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ZxxtdWv">c. Training session and instructions on how to selfapply the tDCS</head><p xml:id="_h4RpGyd"><s xml:id="_78BNpdC">We conducted a training session on how to use the face-to-face equipment when the research team gave the following instructions to participants contained in the manual of tDCS at home: 1) To inspect the skin in the electrode positions to verify any injury that could contraindicate the tDCS use (ie, skin signs of redness, cuts, grazes, etc.).</s><s xml:id="_aAc8EXZ">2) In front of a mirror, do parting hair to expose the stimulation area.</s><s xml:id="_X8caAu7">3) To clean the skin's surface on the electrodes' area to remove creams, dirt, or grease from the skin with alcohol.</s><s xml:id="_yENR7n3">4) Dressing the cap in the head, staying in front of a mirror to see if the seam has positioned between the eyebrows 5) To connect the syringes with saline at the silicone cannulas connected to sponges (use approximately 6 mL for each sponge).</s><s xml:id="_H3mKHwf">6) After the training session, they did the first treatment session under direct supervision at the center.</s><s xml:id="_Ts9ZBts">(7) The research team member who gives instructions on how to use the device gave instructions for patients to access the step-by-step process for selfadministration of tDCS in the following link: <ref type="url" target="https://youtu.be/3Wtji4esOGE">https://  youtu.be/3Wtji4esOGE</ref>).</s><s xml:id="_nTzQH7X">Also, they were instructed to contact the research team if needed at any time.</s></p><p xml:id="_rjxC3pj"><s xml:id="_QeCSdVX">d. Sessions of tDCS at home: protocol compliance, appropriate use, and record of adverse effects They received instructions to choose a quiet time in their daily schedule to apply the treatment session.</s></p><p xml:id="_EDHKp94"><s xml:id="_QdrjPBs">1) The first home-based session (2nd session overall) was under remote supervision.</s><s xml:id="_QQXkdMA">During the treatment period if they had some doubts or problems with the device, instruct them to accesses the team by What-sApp at any time.</s></p><p xml:id="_3YRudYd"><s xml:id="_ZXAxW2W">2) The researcher responsible for communicating with patients contacted them weekly by WhatsApp during the entire treatment period.</s><s xml:id="_aFKGHgt">3) During the treatment sessions, the device registered a sampling of 1 mA and obtained the contact impedance.</s><s xml:id="_CGbJ7Pt">If the contact impedance is beyond the default predefined value for more than 5 seconds, or the current oscillation was more than 10%, the session was interrupted.</s><s xml:id="_Yq3mXYT">4) All sessions were recorded on the tDCS device software.</s><s xml:id="_93U5RB9">This data portraits all sessions and is download at the treatment's end.</s><s xml:id="_pFH5Kzx">Thus, based on these records, we checked the protocol compliance since they contain the hour of use, duration of each session, values of each session's current intensity, and contact impedance.</s><s xml:id="_4qdDNnS">5) They received instructions to report adverse effect's diary immediately after the tDCS home session.</s></p><p xml:id="_46Ztgg9"><s xml:id="_gjpXrPs">To maintain the research team's blinding, an engineer not involved in the patients' treatment downloaded the information registered in the software across treatment time.</s><s xml:id="_CuCZUXS">To see details of the device and step-by-step selfadministration process of the tDCS used at home, see information in this link &lt;https<ref type="url" target="https://www.jove.com/t/57614/home-based-transcranial-direct-current-stimulation-device-development">://www.jove.com/t/57614/  home-based-transcranial-direct-current-stimulation- device-</ref>development&gt;.</s><s xml:id="_cE94U2f">More details about the protocol can see in the supplementary material (tDCS at home protocol).</s><s xml:id="_DmbXjyY">The timeline of the study is presented in Fig <ref type="figure" target="#fig_0">1</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_9tvaASA">Instruments and Assessments</head><p xml:id="_RdZD8rz"><s xml:id="_U2GW8fd">Two independent evaluators that were blind to the group assignments were trained to administer pain scales, conduct the psychological tests, and perform the psychophysical measures.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_c28V37F">Outcomes</head><p xml:id="_yeRTSez"><s xml:id="_e5Ta9Bw">The primary outcomes were the total score on the Pain Catastrophizing Scale <ref type="bibr" target="#b53">54</ref> and the total score on DRP as measured by the Profile of Chronic Pain: Screen (PCP:S). <ref type="bibr" target="#b12">13</ref></s><s xml:id="_CM9hUxb">he secondary outcomes were the subscales of PCS (helplessness, magnification, and rumination), PCP:S subscales (severity, disability, and emotional burden), depressive symptoms, sleep quality, serum BDNF, HPT, and HPTo.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_S4vKYNH">Outcome's Assessments</head><p xml:id="_vUhd69e"><s xml:id="_FFM4v22">Pain Disability due to Pain and Pain Catastrophizing a.</s><s xml:id="_wMxfBvF">The 15-item Profile of Chronic Pain: Screen PCP:S is a selfadministered questionnaire that allows for quick identification of an individual's multidimensional pain experience.</s><s xml:id="_GWj4F6C">It was adapted to the Brazilian Portuguese version with a good psychometric profile. <ref type="bibr" target="#b12">13</ref></s><s xml:id="_nAeYUf9">his tool comprises 3 domains: severity, disability, and emotional burden.</s><s xml:id="_ksH6Dmf">A pain severity index can be calculated by adding the scores on the pain severity items (4 items: possible range 0-30).</s><s xml:id="_4pakM8s">These items comprise the frequency of any pain, the frequency of severe pain, average pain, and the most incredible pain intensity over the past 6 months.</s><s xml:id="_DcKfHTm">The 6 items assessing pain interference on patient function (disability), with 0 = never interferes to 6 = interferes daily.</s><s xml:id="_sgs4XNa">The 6 items assessing pain interference on patient function, with 0 = never interferes to 6 = interferes daily.</s><s xml:id="_C4PBKUj">The interference items ask how often pain interferes with such activities as hobbies, essential self-care, housework, relations with others, personal goals, etc. (6 items: possible range 0-36).</s></p><p xml:id="_93BkeUV"><s xml:id="_BP7kacs">Emotional burden items ascertain how often pain has caused the person to feel sad or depressed, anxious, angry, isolated, or to experience reduced enjoyment of life, with 0 = never to 5 = extremely often (5 items: possible score range 0-25).</s><s xml:id="_bGKZfye">An accepted criterion to define disability related to pain is chronic or recurrent pain or discomfort causing restriction. <ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b62">63</ref></s><s xml:id="_HSUpQbB">Thus, we assumed that higher scores on the B-PCP:S indicated higher disability or functionality at work, at home, during social situations, and/or a higher emotional burden.</s><s xml:id="_2YbGvzD">The PCP:S total score ranges from 0 to 91 points.</s><s xml:id="_2Mbvev9">b.</s><s xml:id="_vvbmUHP">The PCS is a self-administered questionnaire that consists of 13 items to assess catastrophizing related to pain.</s><s xml:id="_sWNKTY3">It adapted to the Brazilian Portuguese version with a good psychometric profile. <ref type="bibr" target="#b53">54</ref></s><s xml:id="_S93Qm6U">It comprises 3 domains: helplessness, magnification, and rumination.</s><s xml:id="_hfqvzh6">Items are rated on a 5-point Likert-type scale in which both intensity and frequency information are represented, with the following 5 levels of response for each Likert item: (0) not at all, (1) to a slight degree, (2) to a moderate degree, (3) to a great degree, (4) and all the time.</s><s xml:id="_Ney8eRA">The 3 domains' scores are given by the sum of the corresponding items (magnification 6, 7, and 13; rumination 8-11; and helplessness 1-5 and 12).</s><s xml:id="_UA4t3AP">The PCS total score ranges from 0 to 52 points.</s></p><p xml:id="_ZHd37kj"><s xml:id="_p7JuTRQ">Psychophysical Measurements, Depressive Symptoms, Sleep Quality, and Serum BDNF c.</s><s xml:id="_VQVw9nq">The HPT was assessed by quantitative sensory testing (QST) using a standardized protocol.</s><s xml:id="_skNxvTw">The measure applies the method limits with a computer Peltierbased device thermode (30 £ 30mm) attached to the skin on the mid-forearm ventral aspect.</s><s xml:id="_VDxSXaa">The temperature thermode was set at 32 degrees Celsius (°C), and it increased at a rate of 1°C/s to a maximum of 52°C.</s><s xml:id="_RXUVPxb">Each participant was instructed to push the button immediately at the moment the stimulation became painful.</s><s xml:id="_mYCEf9G">The HPT of each patient was defined as the means of 3 assessments performed with an inter-stimuli interval of 40 seconds.</s><s xml:id="_dX4EnYx">The mean of 3 HPT assessments was defined as the outcome. 53</s><s xml:id="_sEkX4At">d.</s><s xml:id="_e9mhy22">HPTo is the maximal temperature that the volunteer can support.</s><s xml:id="_Ey8H7pc">It was determined by the method of limits by the same device used to assess the HPT.</s><s xml:id="_U9uEUtx">The stimulus was applied to the ventral area of the midforearm.</s><s xml:id="_W8NbP79">Participants were instructed to push a button when the pain became intolerable.</s><s xml:id="_Qbz6FV7">To avoid injury by thermal stimulus, it stops automatically at 52°C.</s><s xml:id="_dbA4bDy">We performed only a single assessment of HPTo to avoid a possible sensitization effect by repetitive painful stimuli in patients with chronic pain, who might have a reduced pain tolerance.</s><s xml:id="_n6HNYuv">e. Beck Depression Inventory -Second Edition (BDI-II) is a self-application instrument composed of 21 items, whose objective is to measure the intensity of depression from 13 years old to the third age.</s><s xml:id="_vVyYPQX">There is no time limit for completing the protocol, but in general, the BDI-II requires between 5 and 10 minutes to complete. 25</s><s xml:id="_DHrXCZp">f.</s><s xml:id="_Z3RKtGT">Pittsburgh Sleep Quality Index (PSQI) assesses sleep quality and disturbances over the last month.</s><s xml:id="_G6xHBcK">Its 7 components have internal consistency and a reliability coefficient (Cronbach's alpha) of .83.</s><s xml:id="_4YmwDhW">The score sum of 7 components yields the global score of PSQI, which ranges from 0 to 21.</s><s xml:id="_gyGtKbE">The highest score indicates the worst sleep quality. 5</s><s xml:id="_yxMsufp">g.</s><s xml:id="_zhEphYf">Dosage of BDNF serum levels: Blood samples were collected at baseline and after the 20th session at the end of treatment.</s><s xml:id="_BpV8pN2">At the maximum time of one hour after collection, the blood samples were centrifuged, and the serum separated in .5 mL aliquots for further analysis.</s><s xml:id="_jzPMyt8">The BDNF serum levels were determined by sandwich ELISA using monoclonal antibodies specific for the neurotrophin (R&amp;D Systems, Minneapolis) using the manufacturer's protocol.</s></p><p xml:id="_YNDzZRM"><s xml:id="_kp2HpVC">The assayed the samples in duplicate to avoid intraassay variation.</s><s xml:id="_J6WFBRs">Two plates per kit were used over 2 different days, within the same week, to assess the inter-assay variation.</s><s xml:id="_wcgcdkF">Protocols follow the manufacturer's instructions.</s><s xml:id="_5fhrKVV">The Enzyme-linked Immunosorbent was used to determine serum BDNF.</s><s xml:id="_vpfb9FT">The lower detection limit for BDNF of the kit is 7.8 pg/mL.</s><s xml:id="_CkQ5tEX">Assay (ELISA) using a ChemiKine BDNF Sandwich ELISA kit, CYT306 (Chemicon/Millipore, Billerica, Massachusetts,).</s><s xml:id="_3Px7NVS">Optical density was measured using an ELISA reader at a wavelength of 450 nm (GloMax-Multi Microplate Reader, Promega) or the Bio-Plex-200 instrument (Bio-Rad) for the multiplexing assay measurements.</s><s xml:id="_4C9UrCt">We used the standard to measure the total protein by the Bradford method, which uses bovine serum albumin.</s><s xml:id="_AyP7Bqv">The data were expressed in pg/mg of protein.</s></p><p xml:id="_s6gAWZ2"><s xml:id="_WXpen7H">Clinical Measurements: Central sensitization syndrome Symptoms, Anxiety, Pains Score, and Analgesic Use</s></p><p xml:id="_H5PME6V"><s xml:id="_GRg3Vdd">All tests used in this study have been validated for the Brazilian population.</s><s xml:id="_2BGgrgD">To evaluate the quality of life was used the Fibromyalgia Impact Questionnaire .</s><s xml:id="_JT6mf4x">To assess anxiety was used the State-Trait Anxiety Inventory . <ref type="bibr" target="#b32">33</ref></s><s xml:id="_3Pe22bC">he pain intensity was assessed with a 10 NPS.</s><s xml:id="_cvZxAYQ">The NPS ranged from no pain (0) to the worst possible pain (10).</s></p><p xml:id="_Mac98UR"><s xml:id="_syzYRtM">Patients answered the following question using the NPS: 1) Considering your pain, how intense your worst pain was during last week?</s></p><p xml:id="_qsD9p6n"><s xml:id="_2ZxN5cw">The severity of symptoms related to central sensitization syndrome was assessed by the Central Sensitization Inventory (CSI). <ref type="bibr" target="#b11">12</ref></s><s xml:id="_UhM6u7j">The CSI consists of 25 items (total score 0-100) assessing physical symptoms, emotional distress, headache and/or jaw symptoms, and urological symptoms.</s><s xml:id="_rbQhXGp">This scale allows a rapid tracking of symptoms associated with central sensitization to guide therapeutic strategies and indicate prognostic factors.</s><s xml:id="_nucvBE6">Higher scores indicate a higher degree of selfreported symptomatology.</s><s xml:id="_pCZRtRt">The cutoff point for the CSI to define the SSC's presence is a score greater than 40, with a sensitivity of 81% and a specificity of 75% to detect subjects with SSC. <ref type="bibr" target="#b42">43</ref></s><s xml:id="_BMAUtBW">For the analysis, we used the score as a continuous variable.</s></p><p xml:id="_EsJkej9"><s xml:id="_ty4vwJA">Demographic data and medical comorbidities were evaluated using a standardized questionnaire.</s><s xml:id="_p4CXsHj">We used the Systematic Assessment for Treatment questionnaire to assess the side effects of tDCS.</s></p><p xml:id="_Vyn9tVz"><s xml:id="_JQKdzaX">Supplementary analgesia use: They could use additional analgesic medication (acetaminophen, ibuprofen, or tramadol) to relieve their pain if necessary.</s><s xml:id="_dZk5but">They might use 500 mg of acetaminophen up to 4 times per day (QID) at maximum QID as rescue analgesia.</s><s xml:id="_PYrpchZ">If their pain persisted, they could use Dorflex (Sanofi Aventis, São Paulo, Brazil; 35 mg of orphenadrine citrate combined with 300 mg of dipyrone and 50 mg of caffeine) at maximum 3 times per day (TID).</s><s xml:id="_Ujwmepg">In the case that their pain persisted, patients could use tramadol at maximum TID.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ucrKz8q">Statistical Analysis</head><p xml:id="_asHAb5j"><s xml:id="_jEnsV8d">The t-test for independent samples, chi-square, or Fisher's exact tests were used to compare continuous and categorical variables, respectively.</s><s xml:id="_ACC7sz2">To evaluate if the continuous variables presented a normal distribution, we used the Shapiro-Wilk normality test.</s></p><p xml:id="_VtXRVrQ"><s xml:id="_ErN46ck">We analyzed the effect of treatment through a Linear Regression Model.</s><s xml:id="_CmT7gZE">The models included the factor the treatment group (a-tDCS or s-tDCS) used to analyze the main effect on the primary outcomes (pain catastrophizing and disability due to pain) and their subscales assessed after the 20th session.</s><s xml:id="_UY3YbRj">To control the intraindividual variability, we compared the effect of treatment between groups in the primary and secondary outcomes by the mean differences (delta[D]-values, at treatment end minus baseline]). <ref type="bibr" target="#b38">39</ref></s><s xml:id="_dSRZNxE">Pairwise comparisons calculated the main effect of the predicted marginal mean differences between interventions.</s></p><p xml:id="_jCSSbGx"><s xml:id="_cHq9Dyf">In an exploratory analysis, we examined factors associated with the treatment's effect on improving the primary outcomes (pain catastrophizing and disability due to pain).</s><s xml:id="_eCxMDcT">The covariates included in the Generalized Linear Model (GLM) were the delta (D)-values of depressive symptoms in the BDI-II, (D)-values of sleep quality in the PSQI, and serum variation BDNF assessed by the delta (D)-values.</s><s xml:id="_4be25y7">We used this approach based on the delta (D)-values since it recognized that psychophysiological measures show high individual variability upon a stimulus of the same intensity.</s><s xml:id="_TE3T783">We considered all the randomized patients as part of the analysis, using the intention-to-treat method (ITT), with the last observation carried forward.</s><s xml:id="_PwZgHBh">The criteria defined to ITT were previously restricted to subjects who had received at least 25% of total protocol sessions, in the case 5 sessions. <ref type="bibr" target="#b35">36</ref></s><s xml:id="_TrGQybs">Effect size (E.S.) was computed by the standardized difference mean (SDM) (mean difference a-tDCS vs. s-tDCS)/pool of baseline standard deviation (S.D.)].</s><s xml:id="_6f55bsY">The E.S. was interpreted as follows: small if lower than .20 to .49;</s><s xml:id="_pgFCHvS">moderate if between .50 and .79;</s><s xml:id="_hx2KBrk">and large if larger than .80. <ref type="bibr" target="#b33">34</ref> All analyses were adjusted for multiple comparisons by the Bonferroni's test, and they were performed with 2-tailed tests at the 5% significance level.</s><s xml:id="_zAPBJuk">The data were analyzed using SPSS, version 22.0 (SPSS, Chicago, IL).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Bt5yPmR">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_WjaUTcY">Demographic and Clinical Characteristics of the Subjects</head><p xml:id="_NvczgSW"><s xml:id="_6ZZ4BQV">We screened 74 patients; 26 patients did not meet the inclusion criteria.</s><s xml:id="_5uEbQJn">The exclusion criteria are presented in the flow (Fig 2 ).</s><s xml:id="_Xag9wt2">A total of 48 patients were enrolled in this study and randomized to either a-tDCS (n = 32) or s-tDCS (n = 16).</s><s xml:id="_DqjDt9t">Three patients withdrew, 2 in the a-tDCS and one in the s-tDCS, 2 because they did not feel the effect of treatment in a short time, and one did withdraw due to the burning sensation felt during the stimulation session.</s><s xml:id="_BzzSfDJ">We included all of them in the ITT analysis.</s></p><p xml:id="_sHaUGj9"><s xml:id="_kjuRa5D">The clinical and demographic characteristics of the patients are presented in Table <ref type="table" target="#tab_0">1</ref>.</s><s xml:id="_UrzK4ft">There are balanced baseline features between treatment groups.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_TWJgDHC">Primary Outcomes: Impact of tDCS on Pain Catastrophizing and Disability</head><p xml:id="_VR7q5Ge"><s xml:id="_Pkr2asQ">The treatment effect on the primary outcomes (pain catastrophizing thinking and disability due to pain) is presented in Table <ref type="table" target="#tab_1">2</ref>.</s><s xml:id="_DZxYSWE">We showed the mean at baseline and treatment end with the changes in each group's Δ-mean difference with the confidence interval (95% CI) and the E.S. of treatment between groups.</s></p><p xml:id="_Wz5jnA8"><s xml:id="_6pYNc6G">The GLM revealed a main effect for treatment Wald x2 = 5.27; Df = 1; P = .02)</s><s xml:id="_7mcBkyA">in the PCS total score.</s><s xml:id="_Vr25JBD">The effect size was of moderate magnitude (ES = .64).</s><s xml:id="_jZtqKyG">Likewise, this effect was observed in the dominions of rumination and magnification.</s><s xml:id="_xhpq4T9">However, we did not find a statistically significant difference in helplessness.</s></p><p xml:id="_7ZFxyPW"><s xml:id="_UxGsPja">The GLM revealed a main effect for treatment Wald x2 = 4.08; Df = 1; P = .04 in the PCP:S total score.</s><s xml:id="_hAjrxy8">The effect size was of moderate magnitude (ES = .54).</s><s xml:id="_fkXqCq6">Likewise, this effect was observed in the dominions of severity and emotional burden.</s><s xml:id="_k82V9Ht">However, we did not find a statistically significant difference in the domain related to pain interference in daily life activities.</s></p><p xml:id="_7XeFWVr"><s xml:id="_Y5e8nKd">The GLM revealed that a-tDCS compared to s-tDCS reduced total score in the PCS (pain catastrophizing) from baseline to treatment end, by 51.38% and 26.96%, respectively.</s><s xml:id="_qUPD6C5">The treatment effect on the secondary outcomes is presented in Table <ref type="table" target="#tab_2">3</ref>.</s><s xml:id="_q8Rc4xe">We gave the mean at baseline and treatment end with the changes showing each group's Δ-mean difference with the confidence interval (95% CI) and the E.S. of treatment between groups.</s><s xml:id="_A4frxJT">The GLM revealed a main effect for treatment Wald x2 = 3.79; Df = 1; P = .04)</s><s xml:id="_a3Wz68s">in the BDI-II score.</s><s xml:id="_xmg6DAM">The effect size was moderate magnitude (ES = .50).</s><s xml:id="_74N3gky">The GLM revealed a main effect for treatment Wald x2 = 4.36; Df = 1; P = .03)</s><s xml:id="_RbeeUbb">in the PSQI-score.</s><s xml:id="_WWX9DE7">The effect size was moderate magnitude (ES = .62).</s><s xml:id="_xXty9fq">Likewise, we observed a main effect for treatment Wald x2 = 4.06; Df = 1; P = .04)</s><s xml:id="_66jS3WD">in the HPTo with a large effect size (ES = .93).</s><s xml:id="_NSCc7KX">However, we did not find a statistically significant difference in the HPT, neither in Δ-value of BDNF.</s><s xml:id="_4CPgMQF">The positive correlation between the central sensitization scores at baseline with the Δ-BDNF value at the treatment end indicates that subjects with more severe central sensitization symptoms persisted with higher serum BDNF despite the treatment.</s><s xml:id="_3ZX3Xdn">In contrast, higher central sensitization scores at baseline were related to a more significant reduction of depressive symptoms at the treatment end.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_XPqTCtn">Factors Associated With Pain Catastrophizing and Disability due to Pain</head><p xml:id="_BrnrSKU"><s xml:id="_exRtwJS">To examine factors related to the effect of treatment, we conducted an exploratory analysis.</s><s xml:id="_fKrcW3h">The dependent variables in the generalized hierarchical model were the Δ-value of primary outcomes (pain catastrophizing thinking and disability due to pain).</s><s xml:id="_BQe6wVF">The outcome's relationship with independent variables was examined in blocks.</s><s xml:id="_DyvA6dZ">The covariates were retained in the model if they showed a statistically significant association with the dependent variables.</s><s xml:id="_9yRah8J">The results are presented in Table <ref type="table" target="#tab_3">4</ref>.</s><s xml:id="_43PqNsQ">It is important to realize that we are comparing Δ-value (score postminus pre).</s><s xml:id="_Fx72uMW">Thus, a more negative value indicates a larger change, in other words, a more significant effect.</s><s xml:id="_mfQHXus">The improvement in the pain catastrophizing was positively associated with the reduction in the depressive symptoms.</s><s xml:id="_zT2jQz7">In contrast, the treatment effect was more pronounced in those patients who showed larger variation in serum BDNF, in the sense that a higher serum level at the treatment end was related to lower scores in the catastrophizing pain scale.</s><s xml:id="_ZjdSuMD">While the improvement in disability due to pain was positively associated with both improved sleep quality and depressive symptoms.</s><s xml:id="_jjFKNtV">Also, with a reduction in symptoms in the subscale of pain catastrophizing, nominally, magnification and rumination.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ebaCEue">Assessment of Adverse Events and Safety</head><p xml:id="_XBkhVhW"><s xml:id="_YMByp7h">We observed a statistically significant difference between a-tDCS and s-tDCS in the following side effects: tingling, burning, and redness (see Table <ref type="table" target="#tab_4">5</ref>).</s><s xml:id="_zdWPvSA">Mild side effects occurred more often in subjects that received a-tDCS, as well a higher incidence of burning sensation classified as severe was found in the a-tDCS.</s><s xml:id="_2wcNn7G">The cumulative incidence of headache, neck pain, mood swings, and concentration difficulties was reported 10% and 4% of a-tDCS and s-tDCS, respectively.</s><s xml:id="_AbeKH39">Most side effects were classified as mild, even in the patients that decided to stop the treatment due to a burning sensation.</s></p><p xml:id="_v28EE25"><s xml:id="_uEFnnYq">We measured adherence by counting the number of completed sessions as verified by the records on the software.</s><s xml:id="_WJDq9we">The a-tDCS number of sessions administered mean (SD) was18 (3.03); median 20; IQ25-75 = (10; 20) and s-tDCS mean (SD) 19.43(1.98),</s><s xml:id="_PyU2kTq">median 20; IQ25-75 = (14; 22).</s><s xml:id="_YvuhU2A">In the group that received a-tDCD (n = 32), the total number of sessions would be 640 sessions, and we recorded 587 valid sessions (91.71%).</s><s xml:id="_5v3E6Xf">In the group that received s-tDCS (n = 16), there were 278 valid sessions, whereas the total number of sessions would be 320 sessions (86.25%).</s><s xml:id="_Av8Epbf">The total number of scheduled sessions in all samples, considering a-tDCS and s-tDCS, would be 920 sessions, and we recorded 863 valid sessions.</s><s xml:id="_hC9pM6r">Thus, the adherence, including all subjects, was 93.80%.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_BH6HAK3">Discussion</head><p xml:id="_J3JYN8A"><s xml:id="_V5qfezK">These findings reveal that the a-tDCS on the l-DLPFC with cathodal on the r-DLPFC produced a top-down effect of considerable magnitude on primary outcomes related to pain catastrophizing and disability due to pain in the ITT analysis.</s><s xml:id="_ma9rKMB">Additionally, they provide evidence of the a-tDCS benefits to improve secondary outcomes classified as exploratory, such as depressive symptoms, sleep quality, and increased HPTo.</s></p><p xml:id="_hgatDWq"><s xml:id="_PvP2nVW">As far as we know, this is the first study to produce evidence about the impact of the bifrontal tDCS with a-tDCS on the l-DLPFC self-applied at home to modulate the pain sensitivity and the emotional aspects related to pain.</s><s xml:id="_WJgabuU">Nominally, the a-tDCS improved the domains of magnification and rumination of the PCS.</s><s xml:id="_Hz6aEzM">At the same time, we found a-DCS benefits to reduce the PCP:S score related to the severity and emotional burden due to pain.</s><s xml:id="_bWheVnZ">These findings point to the DLPFC as an essential region to modulate the pain experience.</s><s xml:id="_DgWhVc8">They find support in the meta-analysis that found a moderate size effect (.54) in pain due to fibromyalgia with the a-tDCS applied in the l-DLPFC. <ref type="bibr" target="#b67">68</ref></s><s xml:id="_QmshvpB">Likewise, an earlier study in healthy subjects showed that DLPFC stimulation modulates the functional connectivity (FC) of sensory and affective networks. <ref type="bibr" target="#b50">51</ref></s><s xml:id="_5qQzHbw">Also, cumulative data show that anodal l-DLPFC has a beneficial impact on other symptoms related to maladaptive emotional functioning assessed by the SSS score of ACR-2016.</s><s xml:id="_zUPCHkg">Such effects include a reduction in depressive symptoms according to studies in patients with a depression diagnosis, <ref type="bibr" target="#b8">9</ref> improved both working memory, <ref type="bibr" target="#b51">52</ref> and cognitive functions (eg, decision-making). <ref type="bibr" target="#b16">17</ref></s><s xml:id="_Wm944Eg">Also, these findings are consistent with previous studies that showed that painrelated activity within the bilateral DLPFC is negatively correlated with pain catastrophizing. <ref type="bibr" target="#b54">55</ref></s><s xml:id="_BFq75JX">lthough the a-tDCS on l-DLPFC has been targeted in the cortical modulation of pain, it remains unknown how the montage of tDCS can affect structures' function  involved in sensory-affective pain information.</s><s xml:id="_DchUYpK">Earlier studies found that the bifrontal DLPFC stimulation primary modulates FC of both sensory and affective networks, whereas the M1 stimulation modulates FC of sensory networks. <ref type="bibr" target="#b50">51</ref></s><s xml:id="_MpEvKwy">Also, the study found greater FC changes by DLPFC bifrontal tDCS was associated with a larger effect to improve pain tolerance. <ref type="bibr" target="#b50">51</ref></s><s xml:id="_PaZsxmx">Although our study was not designed to compare the impact of different montages on the clinical outcomes, these findings revealed that the bifrontal tDCS with anodal on l-DLPFC produced an effect with a possible clinical relevance on sensory and emotional pain aspects.</s><s xml:id="_VcMM3mg">According to the literature, this effect can be related to improving the imbalance inter-hemisphere, specifically hypoactivity in the l-DLPFC and hyperactivity in the r-DLPFC.</s><s xml:id="_JRsJKsh">Thus, this top-down control can improve biased information processing toward negative stimuli, <ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b28">29</ref> and such effects can explain the improvement of catastrophizing thinking related to pain and depressive symptoms.</s></p><p xml:id="_9jHpbBr"><s xml:id="_yN3JtPU">Although we observed a lack of a statistically significant difference in the mean of Δ-the value of serum BDNF between a-tDCS and sham, a more substantial decrease in serum BDNF from pre-to post-treatment was associated with a significant reduction in disability due to pain (see Table <ref type="table" target="#tab_3">4</ref>).</s><s xml:id="_pcb9vQr">Although the changes in the peripheral BDNF might not reflect a direct effect of the a-tDCS, the current findings suggest that the BDNF is a surrogate marker of the state of neuroplasticity that mediates the tDCS effect in the clinical outcomes. <ref type="bibr" target="#b30">31</ref></s><s xml:id="_sJQKj6z">hese results find support in a previous study in which the value of cerebral spinal fluid changes BDNF after 2 preoperative sessions of a-tDCS on the M1 was  conversely correlated with the DRP at the end of the first postoperative week. <ref type="bibr" target="#b47">48</ref></s><s xml:id="_kZy9TJU">In the same way, other earlier clinical trials in fibromyalgia found that the baseline BDNF predicted the a-tDCS on the l-DLPFC in work memory <ref type="bibr" target="#b51">52</ref> and the home-based a-tDCS effect on the l-DLPFC in the pain scores. <ref type="bibr" target="#b7">8</ref></s><s xml:id="_vjtV3Wm">According to this data set, a-tDCS effects on pain processing depend on the neuroplasticity state, which is assessed indirectly by serum BDNF.</s></p><p xml:id="_5P3ExPW"><s xml:id="_Yr4Y8An">In contrast the Δ-value of pain catastrophizing was conversely associated with Δ-value of BDNF.</s><s xml:id="_YnZjDme">This result indicates that the change of these measure was in the opposite direction.</s><s xml:id="_bTcbqRY">At present, we do not have an explanation for this converse relationship.</s><s xml:id="_fQdUrT4">However, we need to consider that this neurotrophic factor controls a broad spectrum of processes, sometimes exerting opposite effects in the brain, which can be explained based on the specific pattern of its synthesis, with several biologically active isoforms that interact with different types of receptor, finally initiating numerous signaling pathways. <ref type="bibr" target="#b34">35</ref></s><s xml:id="_hq2BtFF">According to pre-clinical study, <ref type="bibr" target="#b58">59</ref> tDCS was able to decrease BDNF levels in the spinal cord and in the brainstem, there were no changes in hippocampus BDNF levels, which may indicate that tDCS activates specific pathways (ie, descending systems) and does not cause general brain activation.</s><s xml:id="_anHn7rF">Another factor that can be involved in the relationship between changes of BDNF and the tDCS effects is the polymorphism of BDNF since the Met allele is associated with reduced cognitive performance, which suggests decreased brain plasticity. <ref type="bibr" target="#b48">49</ref></s><s xml:id="_QJ8dacP">This hypothesis is plausible since in fibromyalgia Val/Val genotype showed higher levels of magnification and rumination of PCS dimensions. <ref type="bibr" target="#b2">3</ref></s><s xml:id="_Gpa8n2p">he tDCS effect on sleep quality improvement agrees with a recent randomized placebo-controlled trial that demonstrated that 20 consecutive daily sessions of frontal transcranial alternating current stimulation (tACS) improved the PSQI score. <ref type="bibr" target="#b64">65</ref></s><s xml:id="_GHPXHHs">This effect on subjective sleep measures after tDCS was found in healthy <ref type="bibr" target="#b55">56</ref> and clinical populations. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b64">65</ref></s><s xml:id="_pjd9Qdd">Notably, these studies found improvements in sleep quality with DCS montages that stimulated frontal and/or motor areas.</s><s xml:id="_MtXntKS">Although the mechanism is not clear, neuroimaging methods identified that cortical topography of slow waves during sleep is primarily associated with activity in a core set of cortical areas mainly located in the PFC and motor regions. <ref type="bibr" target="#b39">40,</ref><ref type="bibr" target="#b40">41</ref></s><s xml:id="_emQ6EPt">ccording to Table <ref type="table" target="#tab_3">4</ref>, a larger reduction in the score PCP: S was associated with higher sleep quality improvement.</s></p><p xml:id="_D269aAm"><s xml:id="_hu8UrxT">According to what was shown in a meta-analysis, the effects of a-tDCS on the HPTo are supported by an extensive number of studies using tDCS to decrease pain. <ref type="bibr" target="#b14">15</ref></s><s xml:id="_DQUBx3y">Although in most studies of meta-analysis, the site to apply the a-tDCS has been the M1, our results suggest that a-tDCS over the l-DLPFC might affect the sensory-discriminative pain processing related to tolerance.</s><s xml:id="_djer8E6">This effect might involve placebo analgesia in downstream circuits to the anterior insula, anterior cingulate cortex (ACC) hypothalamus, and the PAG. <ref type="bibr" target="#b63">64</ref></s><s xml:id="_25Ekr3m">nother hypothesis is that a-tDCS on DLPFC modulates the dorsal part of the premotor cortex, which sends its output to the M1 and spinal cord. <ref type="bibr" target="#b29">30</ref></s><s xml:id="_G7HTpgt">Thus, our findings might be explained by a modulatory effect on the corticospinal pathway. <ref type="bibr" target="#b61">62</ref></s><s xml:id="_RQvmWJc">They also agree with a previous study with fibromyalgia, where the a-tDCS on l-DLPFC improved HPTo. <ref type="bibr" target="#b56">57</ref></s><s xml:id="_n6YCqKZ">However, we did not find improvement on HPT related to the tDCS effect.</s><s xml:id="_pgwM3Jx">This result supports an earlier study with healthy volunteers who assessed the tDCS effect in pain scores by painful electrical stimuli. <ref type="bibr" target="#b15">16</ref></s><s xml:id="_9hTJHkt">Also, they agree with another trial in fibromyalgia with the same montage used at home-based. <ref type="bibr" target="#b7">8</ref> In contrast, another study in fibromyalgia with a-DCS over l-DLPFC and cathodal supra-orbital improved the HPT. <ref type="bibr" target="#b56">57</ref></s><s xml:id="_FwPx6Ec">The findings' inconsistencies across studies might be related to sample characteristics, such as clinical and healthy subjects, the number of tDCS sessions, etc.</s><s xml:id="_anzjNku">This differential effect related to pain might be related to the pain threshold assessment method since the HPT by the QST is a sensitive approach to identify dysfunction in small peripheral sensory fibers, which are part of dysfunction found in fibromyalgia. <ref type="bibr" target="#b6">7</ref></s><s xml:id="_akyVNBu">Thus, these questions likely influence the pain threshold, and they should be considered in further studies.</s></p><p xml:id="_ndxZKjf"><s xml:id="_mFsVgpy">In the interpretation of these results, some methodological aspects and limitations should be borne in mind.</s><s xml:id="_fPceZq3">First, these findings support the use of bifrontal tDCS with a-tDCS over the l-DLPFC to improve fibromyalgia symptoms.</s><s xml:id="_kYG4t3z">However, we did not compare with different stimulation sites and different parameters, including frequency, current, and duration of the treatment.</s><s xml:id="_pkW3XBg">Second, we included only females to avoid the confounding effect of sex based on the following reasons: 1) There is vast literature related to sex differences in pain sensitivity, <ref type="bibr" target="#b3">4</ref> and fibromyalgia is more prevalent in women.</s><s xml:id="_PWkuSk6">2) Women showed a higher medial prefrontal activation under nociceptive stimuli <ref type="bibr" target="#b27">28</ref> and higher inhibition of the descending pain modulating system than males. <ref type="bibr" target="#b22">23</ref></s><s xml:id="_9k69Ayx">3) Incipient data indicate that females are prone to developing a long-term depression (LTD) effect by tDCS longer than men. <ref type="bibr" target="#b51">52</ref></s><s xml:id="_y74u4He">Third, we used a rigorous and replicable methodology that evidenced the effectiveness and the feasibility of t-DCS at home, as attested by adherence rate higher than 85% of sessions applied in both a-tDCS and s-sham tDCS.</s><s xml:id="_3KhfuRY">Fourth, the adverse events observed in our study are like previously reported in trials of tDCS. <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b26">27</ref></s><s xml:id="_BYq6PE2">Despite local skin reactions, patients did not correctly guess the assignment to tDCS.</s></p><p xml:id="_Khpgb9c"><s xml:id="_jUHvFtw">In conclusion, these findings revealed the efficacy of home-based self-applied a-tDCS on the l-DLPFC and cathodal on the r-DLPFC reduced both pain catastrophizing and disability due to pain in fibromyalgia.</s><s xml:id="_Z7mSYRy">Also, our results revealed that the a-tDCS improved sleep quality, depressive symptoms, and that the tDCS effect in disability due to pain is associated with decreased serum BDNF.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p xml:id="_ZU5b3Hb"><s xml:id="_RdsSh72">Figure 1.</s><s xml:id="_PTk5WSx">Timeline the study.</s><s xml:id="_s5jHhwj">(A) Position of electrodes on the DLPFC (dorsolateral prefrontal cortex).</s><s xml:id="_kzbrBG7">Display of tDCS showing (B) resistance and impedance and (C) instructions to adjust the cap and inject the saline solution.</s><s xml:id="_QgyHxUK">D: Typical curves of current intensity versus contact impedance during a tDCS session.</s><s xml:id="_XFmMTjZ">(D) An example of current intensity and contact impedance curves (healthy subject).</s><s xml:id="_SaZSYFa">Current intensity (mA): Red line.</s><s xml:id="_xRVxNsU">Resistance (KV): Blue line.</s></p></div></figDesc><graphic coords="5,60.66,60.61,470.64,265.37" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><figDesc><div><p xml:id="_VYXV9PV"><s xml:id="_GJfW4pD">Fig 3 A presents these differences in the marginal means by pairwise comparisons adjusted for multiple comparisons by the Bonferroni's test in the PCP: S. The GLM revealed that a-tDCS compared to s-tDCS reduced total score in the PCP:S (disability due to pain) from baseline to treatment end, by 31.43% and 19.15%, respectively.</s><s xml:id="_wpvuPH6">Fig 3B presents these differences in the marginal means by pairwise comparisons adjusted for multiple comparisons by the Bonferroni's test in the PCP:S Secondary Outcomes: Impact of tDCS on HPT, HPTo, Sleep Quality, Depressive Symptoms and BDNF</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2 .</head><label>2</label><figDesc><div><p xml:id="_7wD5vB4"><s xml:id="_7SUUqq4">Figure 2. Flowchart of the study.</s></p></div></figDesc><graphic coords="7,96.72,533.14,398.64,207.77" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><figDesc><div><p xml:id="_rfHFPdg"><s xml:id="_2b8dSS6">Abbreviations: PCP:S -Brazilian Portuguese version of the Profile of Chronic Pain: Screen total score; PCS -Brazilian Portuguese Pain Catastrophizing Scale; B -beta value; SEM -standardized error of mean; Df -Degrees of freedom.</s><s xml:id="_SUGFRgR">Delta (Δ)-value mean difference (post-treatment minus pretreatment); Degrees of freedom (Df).</s><s xml:id="_n53SzgW">yGeneralized Linear Models Mean difference groups.Effect size (ES) (Mean difference a-tDCS vs. s-tDCS)/Standard deviation on s-tDCS].</s><s xml:id="_8qhgVpd">The ES was defined as small if lower than .20 to .49;</s><s xml:id="_D582qrJ">moderate if between 0.50 and .79;</s><s xml:id="_C8vj6y2">and large if larger than .80.Effect of treatment on pain catastrophizing, in the total score of the PCS and PCP:S and their subscales: Mean (standard deviation, SD), Δ-value of mean difference with the confidence interval (95% CI) and effect size (ES) (n = 48).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 3 .</head><label>3</label><figDesc><div><p xml:id="_yNvZTkp"><s xml:id="_ER85z7d">Figure 3. (A).</s><s xml:id="_qdquQD3">Mean in the Pain Catastrophizing Scale -PCS and (B) PCP:S -Profile of Chronic Pain: Screen total score to assess the disability due to pain for daily activities from baseline to the 4th week at treatment end, according to the 2 experimental groups.The error bars show the standard error of the mean (SEM).</s><s xml:id="_YPJZtr7">Asterisks (*) positioned above the bars indicate significant differences (P&lt;0.01) between the s-tDCS and the a-tDCS groups.</s><s xml:id="_5xA7KRz">All comparisons were performed by a Generalized Linear Models, followed by the Bonferroni correction for post hoc multiple comparisons.</s></p></div></figDesc><graphic coords="10,146.72,60.61,302.40,396.41" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_Sx5cEXU"><s xml:id="_TYFAQSQ">Epidemiological and Clinical Characteristics at Baseline, According to the Treatment Group, Values are Given as the Mean (SD) or Frequency (n = 48)</s></p></div></figDesc><table><row><cell>CHARACTERISTICS</cell><cell>A-TDCS (N = 32)</cell><cell>S-TDCS (N = 16)</cell><cell>P-VALUE</cell></row><row><cell>Age (y)</cell><cell>49.6 (9.00)</cell><cell>48.0 (6.72)</cell><cell>.56</cell></row><row><cell>Level of education (y)</cell><cell>11.33 (4.15)</cell><cell>12.11 (4.04)</cell><cell>.53</cell></row><row><cell>Smoking (yes/no)</cell><cell>6 (20) / 24 (80)</cell><cell>11 (6.25) /15 (93.75)</cell><cell>.17</cell></row><row><cell>Alcohol use (yes/no)</cell><cell>11 (36.7) /19 (63.5)</cell><cell>5 (27.8) / 11(72.2)</cell><cell>.38</cell></row><row><cell>History of chronic disease (yes/no)</cell><cell>15 (50) / 15 (50)</cell><cell>10 (62.5) / 6 (37.5)</cell><cell>.31</cell></row><row><cell>Hypertension (yes/no)</cell><cell>7 (23.30)</cell><cell>5 (27.8)</cell><cell></cell></row><row><cell>Type 2 Diabetes Mellitus (yes/no)</cell><cell>1 (3.33)</cell><cell>2 (11.1)</cell><cell></cell></row><row><cell>Asthma (yes/no)</cell><cell>2 (6.7)</cell><cell>0</cell><cell></cell></row><row><cell>Hypothyroidism</cell><cell>3 (10)</cell><cell>1 (5.6)</cell><cell></cell></row><row><cell>Central Sensitization inventory (CSI-BP) score</cell><cell>57.23 (12.00)</cell><cell>60.38 (13.26)</cell><cell></cell></row><row><cell>State-Trait Anxiety Inventory -State</cell><cell>28.55 (5.80)</cell><cell>30.33 (8.00)</cell><cell></cell></row><row><cell>State-Trait Anxiety Inventory -Trait</cell><cell>23.24 (4.39)</cell><cell>22.27 (4.08)</cell><cell></cell></row><row><cell>Pittsburgh Sleep Quality Index -PSQI</cell><cell>18.43 (9.18)</cell><cell>20.83 (8.70)</cell><cell></cell></row><row><cell>Fibromyalgia Impact Questionnaire -FIQ</cell><cell>70.20 (15.12)</cell><cell>65.88 (15.53)</cell><cell></cell></row><row><cell>Pain on visual analogue scale (VAS)</cell><cell>7.04 (1.39)</cell><cell>7.56 (1.26)</cell><cell></cell></row><row><cell>Number of non-opioid analgesic used daily weekly (≥ 4d / &lt; 4d)**</cell><cell>20 (66.7) /10 (33.30)</cell><cell>13 (72.2) / (5) 27.8</cell><cell>.47</cell></row><row><cell></cell><cell>Acetaminophen (Yes)</cell><cell>10 (33.)</cell><cell>4 (25)</cell></row><row><cell></cell><cell>Dipyrone (Yes)</cell><cell>9 (30)</cell><cell>5 (31.2)</cell></row><row><cell></cell><cell>Dorflex (Yes)</cell><cell>12 (40)</cell><cell>8 (50)</cell></row><row><cell></cell><cell>NSAID (Yes)</cell><cell>4 (13.3)</cell><cell>1 (6.3)</cell></row><row><cell>Skeletal muscle relaxants</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Cyclobenzaprine</cell><cell>11 (36.7)</cell><cell></cell></row><row><cell></cell><cell>Carisoprodol plus Diclofenac (75 mg)</cell><cell>6 (20)</cell><cell></cell></row><row><cell>Type of opioid medication (Yes/No) **</cell><cell>8 (26.7) / 20(66.7)</cell><cell>5 (31.33) / 11(68.80)</cell><cell>.18</cell></row><row><cell></cell><cell>Codeine</cell><cell>3 (10)</cell><cell>1 (6.25)</cell></row><row><cell></cell><cell>Oxycodone</cell><cell>2 (7.14)</cell><cell>2 (12.5)</cell></row><row><cell></cell><cell>Tramadol $</cell><cell>6 (20)</cell><cell>2 (12.5)</cell></row><row><cell>Psychiatric disorder according to the MINI (Yes/No) *</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Major depressive episode with dysthymia (Yes/No)</cell><cell>22 (73.9) / 10 (33.3)</cell><cell>11 (68.8) /5 (31.33)</cell><cell>.50</cell></row><row><cell>Post-traumatic stress disorder (Yes/No)</cell><cell>5 (16.7) /25 (83.3)</cell><cell>4 (25) /12 (75)</cell><cell>.38</cell></row><row><cell>Generalized anxiety disorder (Yes/No)</cell><cell>10 (33.3) / 20 (66.7)</cell><cell>7 (43.8)/ 9 (56.3)</cell><cell>.18</cell></row><row><cell>Active central nervous system medication</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Antidepressant Yes/No y</cell><cell>20 (66.7) / 10 (33.33)</cell><cell>13 (81.3) /3 (18.8)</cell><cell>.25</cell></row><row><cell>Antidepressant tricyclic or dual (Yes)</cell><cell>6 (20)</cell><cell>6 (37.5)</cell><cell></cell></row><row><cell>Antidepressant dual (Yes)</cell><cell>9 (30)</cell><cell>2 (12.5)</cell><cell></cell></row><row><cell>Antidepressants selective serotonin reuptake inhibitors (Yes)</cell><cell>8 (26.2)</cell><cell>6 (37.5)</cell><cell></cell></row><row><cell>Anticonvulsant Yes/No y</cell><cell>4 (13.33) /26 (86.7)</cell><cell>6 (37.5) /10 (62.5)</cell><cell>.07</cell></row><row><cell>Pregabaline (Yes)</cell><cell>3 (10)</cell><cell>4 (25)</cell><cell></cell></row><row><cell>Gabapentine (Yes)</cell><cell>1 (3.33)</cell><cell>2 (12.5)</cell><cell></cell></row><row><cell>Benzodiazepine (Yes)</cell><cell>4 (13.3)</cell><cell>6 (37.5)</cell><cell></cell></row><row><cell>Zolpidem (Yes)</cell><cell>1 (3.33)</cell><cell>2 (12.5)</cell><cell></cell></row><row><cell>Quetiapine (Yes)</cell><cell>1 (3.33)</cell><cell>0</cell><cell></cell></row></table><note xml:id="_h5bnnbE"><p><s xml:id="_Z4msPZw">*Patients could have none or more than one diagnostic according to Central Sensitization Inventory.</s><s xml:id="_ahzJu7S">ySome patients were using more than one type of drug.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p xml:id="_hhb34ru"><s xml:id="_Uyqbkpv">Primary Outcomes</s></p></div></figDesc><table><row><cell></cell><cell cols="4">MEAN (SD)</cell><cell cols="2">MEAN (SD)</cell><cell>Δ-VALUE</cell><cell>BETA</cell><cell>SEM</cell><cell>CI 95%</cell><cell>WALD x2 DF</cell><cell>P</cell><cell>ES</cell></row><row><cell></cell><cell cols="4">BEFORE (B) TREATMENT</cell><cell cols="2">AFTER (A) TREATMENT</cell><cell></cell><cell></cell></row><row><cell cols="7">Primary outcome: Treatment effect on pain catastrophizing</cell><cell></cell><cell></cell></row><row><cell cols="5">Pain Catastrophizing Scale -PCS</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>a-tDCS (n = 32)</cell><cell></cell><cell></cell><cell cols="2">32.33 (13.11)</cell><cell></cell><cell>15.72 (9.35)</cell><cell>-17.32 (12.76)</cell><cell>-10.75</cell><cell>4.68 (-19.94 to -1.54) 5.27</cell><cell>1 .02 .64</cell></row><row><cell>s-tDCS (n = 16)</cell><cell></cell><cell></cell><cell cols="2">28.44 (14.98)</cell><cell></cell><cell>20.77 (8.49)</cell><cell>-6.56 (16.69)</cell><cell>0 reference</cell></row><row><cell cols="8">Secondary outcomes: Pain Catastrophizing Scale -PCS -domains</cell><cell></cell></row><row><cell>PCS -Rumination</cell><cell>y</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>a-tDCS (n=32)</cell><cell></cell><cell></cell><cell cols="2">12.60 (5.15)</cell><cell></cell><cell>5.93 (4.11)</cell><cell>-7.10 (4.56)</cell><cell>-3.15</cell><cell>1.57 (-6.24 to -0.08) 4.03</cell><cell>1 .04 .47</cell></row><row><cell>s-tDCS (n = 16)</cell><cell></cell><cell></cell><cell cols="2">11.00 (5.85)</cell><cell></cell><cell>7.05 (4.11)</cell><cell>-6.56 (6.69)</cell><cell>0 reference</cell></row><row><cell cols="3">PCS -Magnification</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>a-tDCS (n = 32)</cell><cell></cell><cell></cell><cell cols="2">7.60 (3.69)</cell><cell></cell><cell>3.86 (2.61)</cell><cell>-4.06 (2.76)</cell><cell>-3.013</cell><cell>1.19 (-5.36 to -0.67) 6.35</cell><cell>1 .01 .63</cell></row><row><cell>s-tDCS (n = 16)</cell><cell></cell><cell></cell><cell cols="2">6.61 (4.17)</cell><cell></cell><cell>5.55 (2.57)</cell><cell>-1.05 (4.73)</cell><cell>0 reference</cell></row><row><cell cols="2">PCS -Helplessness</cell><cell>y</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>a-tDCS (n = 32)</cell><cell></cell><cell></cell><cell cols="2">12.13 (6.37)</cell><cell></cell><cell>5.93 (3.41)</cell><cell>-6.17 (6.96)</cell><cell>-3.506</cell><cell>2.13 (-7.62 to 0.62)</cell><cell>2.70</cell><cell>1 .10 --</cell></row><row><cell>s-tDCS (n = 16)</cell><cell></cell><cell></cell><cell cols="2">10.83 (6.11)</cell><cell></cell><cell>8.16 (3.83)</cell><cell>-2.67 (7.48)</cell><cell>0 reference</cell></row><row><cell cols="10">Primary outcome: Profile of Chronic Pain: Screen (PCP:S) total score -disability due to pain</cell><cell>y</cell></row><row><cell>a-tDCS (n = 32)</cell><cell></cell><cell></cell><cell cols="2">68.84 (14.89)</cell><cell></cell><cell>47.20 (17.23)</cell><cell cols="2">-21.85(14.41) -11.67</cell><cell>5.77 (-22.99 to -.36) 4.08</cell><cell>1 .04 .54</cell></row><row><cell>s-tDCS (n = 16)</cell><cell></cell><cell></cell><cell cols="2">67.45 (17.46)</cell><cell></cell><cell>54.53 (19.09)</cell><cell cols="2">-10.17(21.35) 0 reference</cell></row><row><cell cols="8">Secondary outcomes: Profile of Chronic Pain: Screen (PCP:S) -domains</cell><cell></cell></row><row><cell cols="3">PCP:S -pain severity</cell><cell>y</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>a-tDCS (n = 32)</cell><cell></cell><cell></cell><cell cols="2">24.98 (3.12)</cell><cell></cell><cell>17.65 (4.94)</cell><cell>-7.32 (4.26)</cell><cell>-3.456</cell><cell>1.48 -6.36 to -0.55</cell><cell>5.44</cell><cell>1 .02 .58</cell></row><row><cell>s-tDCS (n = 16)</cell><cell></cell><cell></cell><cell cols="2">23.85 (5.81)</cell><cell></cell><cell>19.98 (5.49)</cell><cell>-3.87 (6.12)</cell><cell>0 reference</cell></row><row><cell cols="6">PCP:S -interference in daily life activities</cell><cell>y</cell><cell></cell><cell></cell></row><row><cell>a-tDCS (n = 32)</cell><cell></cell><cell></cell><cell cols="2">27.86 (8.67)</cell><cell></cell><cell>18.58 (7.66)</cell><cell>-9.06 (9.20)</cell><cell>-3.019</cell><cell>3.20 (-9.29 to 3.25)</cell><cell>0.88</cell><cell>1 0.34 --</cell></row><row><cell>s-tDCS (n = 16)</cell><cell></cell><cell></cell><cell cols="2">28.94 (11.05)</cell><cell></cell><cell>22.89 (6.47)</cell><cell>-6.05 (13.25)</cell><cell>0 reference</cell></row><row><cell cols="4">PCP:S -emotional burden</cell><cell>y</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>a-tDCS (n = 32)</cell><cell></cell><cell></cell><cell cols="2">16.00 (5.44)</cell><cell></cell><cell>11.20 (6.71)</cell><cell>-4.75 (6.46)</cell><cell>-4.981</cell><cell>2.16 (-9.23 to -0.73) 5.28</cell><cell>1 .022 0.66</cell></row><row><cell>s-tDCS (n = 16)</cell><cell></cell><cell></cell><cell cols="2">14.66 (6.00)</cell><cell></cell><cell>14.88 (4.74)</cell><cell>.22 (8.68)</cell><cell>0 reference</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 .</head><label>3</label><figDesc><div><p><s xml:id="_KcM3SNN">Secondary OutcomesGeneralized Linear Models Mean difference groups.Effect size (ES) (Mean difference a-tDCS vs s-tDCS)/Standard deviation on s-tDCS].</s><s xml:id="_FKC5g5K">The ES was defined as small if lower than .20 to .49;</s><s xml:id="_j6zPAu2">moderate if between .50 and .79;</s><s xml:id="_E2qZx6t">and large if larger than .80.Effect of treatment on depressive symptoms, sleep quality, BDNF, HPT and HPTo pain between Groups: Mean (standard deviation, SD), Δ-value of mean difference with the confidence interval (95% CI) and effect size (ES) (n = 48).</s></p></div></figDesc><table><row><cell></cell><cell>MEAN (SD)</cell><cell>MEAN (SD)</cell><cell>Δ-VALUE</cell><cell>BETA</cell><cell>SEM</cell><cell>CI 95%</cell><cell>WALD x2</cell><cell>DF</cell><cell>P</cell><cell>ES</cell></row><row><cell></cell><cell>BEFORE (B) TREATMENT</cell><cell>AFTER (A) TREATMENT</cell><cell>(B MINUS A)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Secondary outcomes</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Beck Depressive Inventory -II (BDI II) *</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>a-tDCS</cell><cell>26.03 (11.56)</cell><cell>13.43 (7.75)</cell><cell>-12.60(11.27)</cell><cell>-7.57</cell><cell>3.79</cell><cell>(-15.01 to -0.14)</cell><cell>3.98</cell><cell>1</cell><cell>.04</cell><cell>0.50</cell></row><row><cell>s-tDCS</cell><cell>24.61 (11.66)</cell><cell>18.77 (9.97)</cell><cell>-5.83 (14.90)</cell><cell>0 reference</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Central Sensitization Inventory score at baseline</cell><cell></cell><cell></cell><cell></cell><cell>-.25</cell><cell>.11</cell><cell>(-.48 to -0.3)</cell><cell>4.87</cell><cell>1</cell><cell>.02</cell><cell></cell></row><row><cell>Pittsburgh Sleep Quality Index (PSQI)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>a-tDCS</cell><cell>16.20 (6.07)</cell><cell>8.50 (4.44)</cell><cell>-8.33 (6.57)</cell><cell>-5.362</cell><cell>2.56</cell><cell>(-10.39 to -.33)</cell><cell>4.36</cell><cell>1</cell><cell>.03</cell><cell>0.62</cell></row><row><cell>s-tDCS</cell><cell>11.22 (5.89)</cell><cell>7.89 (5.01)</cell><cell>-3.33 (8.59)</cell><cell>0 reference</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Central Sensitization Inventory score at baseline</cell><cell></cell><cell></cell><cell></cell><cell>-.080</cell><cell>.11</cell><cell>(-.31 to 0.15)</cell><cell>.445</cell><cell>1</cell><cell>.50</cell><cell></cell></row><row><cell cols="2">Brain-derived neurotrophic factor (BDNF) ng⁄mL</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>a-tDCS</cell><cell>35.51 (21.54)</cell><cell>36.30 (30.00)</cell><cell>.89 (18.98)</cell><cell>1.838</cell><cell>4.18</cell><cell>(-6.37 to 10.05)</cell><cell>.192</cell><cell>1</cell><cell>.66</cell><cell>--</cell></row><row><cell>s-tDCS</cell><cell>27.32 (21.24)</cell><cell>28.26 (26.26)</cell><cell>.94 (19.19)</cell><cell>0 reference</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Central Sensitization Inventory score at baseline</cell><cell></cell><cell></cell><cell></cell><cell>.392</cell><cell>.186</cell><cell>(.03 to 0.76)</cell><cell>4.41</cell><cell>1</cell><cell>.03</cell><cell></cell></row><row><cell>Heat pain tolerance (°C)*</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>a-tDCS</cell><cell>43.29 (3.91)</cell><cell>44.69 (2.59)</cell><cell>1.40 (3.27)</cell><cell>1.86</cell><cell>.92</cell><cell>(.05 to 3.68)</cell><cell>4.06</cell><cell>1</cell><cell>.04</cell><cell>0.93</cell></row><row><cell>s-tDCS</cell><cell>45.15 (3.87)</cell><cell>44.68 2.27)</cell><cell>-.46 (2.7()</cell><cell>0 reference</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Heat pain threshold (°C)*</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>a-tDCS</cell><cell>37.41 (2.87)</cell><cell>37.38 (2.56)</cell><cell>-.11 (2.33)</cell><cell>-.019</cell><cell>.628</cell><cell>(-1.25 to 1.21)</cell><cell>.001</cell><cell>1</cell><cell>.97</cell><cell>--</cell></row><row><cell>s-tDCS</cell><cell>36.46 (1.47)</cell><cell>36.37 (2.40)</cell><cell>-.09 (1.98)</cell><cell>0 reference</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">Δ-delta value mean value (posttreatment minus pretreatment).</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note xml:id="_mYACZcn"><p><s xml:id="_jpYkWdG">*</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 4 .</head><label>4</label><figDesc><div><p xml:id="_WQYuSMN"><s xml:id="_te4wvhM">Predictors of Treatment Effect on Pain Catastrophizing and Disability due to Pain (n = 48)</s></p></div></figDesc><table><row><cell>D-CATASTROPHIZING SCALE -PCS y</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>BETA</cell><cell>SEM</cell><cell>CI 95%</cell><cell>WALD x2</cell><cell>DF</cell><cell>P</cell></row><row><cell>(Intercept)</cell><cell>-1.318</cell><cell>3.7018</cell><cell>(-8.57 to 5.93)</cell><cell>.127</cell><cell>1</cell><cell>.722</cell></row><row><cell>a-tDCS (n = 32)</cell><cell>-8.943</cell><cell>4.0726</cell><cell>(-16.92 to -.96)</cell><cell>4.822</cell><cell>1</cell><cell>.028</cell></row><row><cell>s-tDCS (n = 16)</cell><cell>0 reference</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Δ-Beck Depressive Inventory -II (BDI II)</cell><cell>.405</cell><cell>.1525</cell><cell>(.10-.70)</cell><cell>7.056</cell><cell>1</cell><cell>.008 y</cell></row><row><cell>Δ-Pittsburg Sleep Quality Index (PSQI</cell><cell>.296</cell><cell>.1899</cell><cell>(-.08 to .07)</cell><cell>2.438 y</cell><cell>1</cell><cell>.118 y</cell></row><row><cell>Δ-Brain-derived neurotrophic factor</cell><cell>-.252</cell><cell>.1225</cell><cell>(-.49 to -.02)</cell><cell>4.223</cell><cell>1</cell><cell>.040 z</cell></row><row><cell cols="2">D-PROFILE OF CHRONIC PAIN: SCREEN (PCP:S) -DISABILITY DUE TO PAIN</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>BETA</cell><cell>SEM</cell><cell>CI 95%</cell><cell>WALD x2</cell><cell>DF</cell><cell>P</cell></row><row><cell>(Intercept)</cell><cell>60.463</cell><cell>.3135</cell><cell>(59.84-61.08)</cell><cell>37202.660</cell><cell>1</cell><cell>.000</cell></row><row><cell>a-tDCS (n = 32)</cell><cell>-5.229</cell><cell>.3324</cell><cell>(-5.88 to -4.58)</cell><cell>247.436</cell><cell>1</cell><cell>.000*</cell></row><row><cell>s-tDCS (n = 16)</cell><cell>0 reference</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Δ-Pittsburg Sleep Quality Index (PSQI</cell><cell>.328</cell><cell>.0150</cell><cell>(.29 to .36)</cell><cell>480.163</cell><cell>1</cell><cell>.000 y</cell></row><row><cell>Δ-Beck Depressive Inventory -II (BDI</cell><cell>.231</cell><cell>.0131</cell><cell>.(20 to .26)</cell><cell>313.291</cell><cell>1</cell><cell>.000 y</cell></row><row><cell>Δ-Brain-derived neurotrophic factor</cell><cell>.225</cell><cell>.0107</cell><cell>(.20-.25)</cell><cell>439.96</cell><cell>1</cell><cell>000 z</cell></row><row><cell>Δ-PCS -Rumination</cell><cell>.163</cell><cell>.0453</cell><cell>(.08-.25)</cell><cell>12.999</cell><cell>1</cell><cell>.000 x</cell></row><row><cell>Δ -PCS -Magnification</cell><cell>.393</cell><cell>.0636</cell><cell>(.27-.52)</cell><cell>38.165</cell><cell>1</cell><cell>.000 x</cell></row></table><note xml:id="_Bnax7n9"><p><s xml:id="_RJjuQZ2">*Model 1: First blockage, level of education; analgesic use (4 or more than 4 days per week), psychotropic medication (antidepressant and anticonvulsants).</s><s xml:id="_BumfVnW">yModel 2. Δ-Pittsburg Sleep Quality Index (PSQI, Δ-Beck Depressive Inventory -II (BDI II), Central Sensitization Inventory; psychiatric diagnoses according to the MINI (major depressive episode with dysthymia, mania-depressive disorder, and generalized anxiety disorder.</s><s xml:id="_bppSpwa">zModel 3: Third block -Δ-Brain-derived neurotrophic factor.</s><s xml:id="_RYxtvvR">xModel 4. Fourth block -Δ-PCS -Magnification; Δ-PCS -Rumination.</s><s xml:id="_tXdAFBG">This Block was included in the model with the dependent variable the Δ-Profile of Chronic Pain: Screen (PCP:S).</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 5 .</head><label>5</label><figDesc><div><p xml:id="_9Ut8gbx"><s xml:id="_Z5G63tr">Side Effects Presented as Percentage (%), and the Incidence or Severity of Side Effects Classified as Mild, Moderate, and Severe (n = 48)</s></p></div></figDesc><table><row><cell>SEVERITY OF SYMPTOMS (%)</cell></row></table></figure>
		</body>
		<back>

			<div type="funding">
<div xml:id="_UdC2A9Y"><p xml:id="_8B7DNem"><s xml:id="_Nkpfdtk">The present research was supported by the following <rs type="funder">Brazilian</rs> funding agencies: (i) Committee for the <rs type="funder">Development of Higher Education Personnel-CAPES PNPD</rs> (grant to C.S. with Postdoctoral scholarship, Grant #<rs type="grantNumber">2018</rs>; <rs type="funder">CFSA</rs>, L.R.).</s><s xml:id="_wvXEb9J">(ii) <rs type="funder">National Council for Scientific and Technological Development -CNPq</rs> (grant to W.C. number: <rs type="grantNumber">420826/2018-1</rs>).</s><s xml:id="_Pmu8NW6">(iii) <rs type="funder">Foundation for the Support of Research at Rio Grande do Sul (FAPERGS) Ministry of Science and Technology.National Council for Scientific and Technological Development -(CNPq)/ Health Secretary of state of Rio Grande do Sul, Brazil</rs> (SEARS) n. <rs type="grantNumber">03/2017</rs> (<rs type="projectName">PPSUS</rs>) (number: <rs type="grantNumber">17/2551-0001</rs>).</s><s xml:id="_Z8Mnptt">(iv) <rs type="funder">Postgraduate Research Group</rs> at the <rs type="funder">Hospital de Cl ınicas de Porto Alegre</rs> (AS, PS, DS).</s></p><p xml:id="_jUMZTcH"><s xml:id="_tqz6Zym">Conflict of Interest Statement: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</s></p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_pNTX4yH">
					<idno type="grant-number">2018</idno>
				</org>
				<org type="funding" xml:id="_np8xP88">
					<idno type="grant-number">420826/2018-1</idno>
				</org>
				<org type="funded-project" xml:id="_6cKqN7m">
					<idno type="grant-number">03/2017</idno>
					<orgName type="project" subtype="full">PPSUS</orgName>
				</org>
				<org type="funding" xml:id="_HtCNh3p">
					<idno type="grant-number">17/2551-0001</idno>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_srgb8uM">Supplementary data</head><p xml:id="_QvbketV"><s xml:id="_pHE5HTJ">Supplementary data related to this article can be found at <ref type="url" target="https://doi.org/10.1016/j.jpain.2021.11.002">https://doi.org/10.1016/j.jpain.2021.11.002</ref>.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_ee5BAbQ">Transcranial direct current stimulation (tDCS) for sleep disturbances and fatigue in patients with post-polio syndrome</title>
		<author>
			<persName><forename type="first">M</forename><surname>Acler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Bocci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Valenti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Turri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Priori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bertolasi</surname></persName>
		</author>
		<idno type="DOI">10.3233/rnn-130321</idno>
		<ptr target="https://doi.org/10.3233/RNN-130321" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_ADXQFdw">Restor Neurol Neurosci</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="661" to="668" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Acler M, Bocci T, Valenti D, Turri M, Priori A, Bertolasi L: Transcranial direct current stimulation (tDCS) for sleep dis- turbances and fatigue in patients with post-polio syn- drome. Restor Neurol Neurosci 31:661-668, 2013. https:// doi.org/10.3233/RNN-130321</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_gYgSCTa">Cognitive-affective neural plasticity following active-controlled mindfulness intervention</title>
		<author>
			<persName><forename type="first">M</forename><surname>Allen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dietz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Blair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Van Beek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Rees</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Vestergaard-Poulsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lutz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Roepstorff</surname></persName>
		</author>
		<idno type="DOI">10.1523/jneurosci.2957-12.2012</idno>
		<ptr target="https://doi.org/10.1523/JNEUROSCI.2957-12.2012" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_zFfb6KK">J Neurosci</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="15601" to="15610" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Allen M, Dietz M, Blair KS, van Beek M, Rees G, Vester- gaard-Poulsen P, Lutz A, Roepstorff A: Cognitive-affective neural plasticity following active-controlled mindfulness intervention. J Neurosci 32:15601-15610, 2012. https://doi. org/10.1523/JNEUROSCI.2957-12.2012</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_MesY7R3">Pain catastrophizing is associated with the Val66Met polymorphism of the brain-derived neurotrophic factor in fibromyalgia</title>
		<author>
			<persName><forename type="first">C</forename><surname>Alves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Caumo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Silvestri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zortea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">S</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Cardoso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Regner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>H€ Ubner De Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Simon</surname></persName>
		</author>
		<idno type="DOI">10.1186/s42358-020-00141-9</idno>
		<ptr target="https://doi.org/10.1186/s42358-020-00141-9" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_tp4c9RG">Adv Rheumatol</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="issue">39</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Alves C, Caumo W, Silvestri JM, Zortea M, Santos VS, Car- doso DF, Regner A, H€ ubner de Souza A, Simon D: Pain cata- strophizing is associated with the Val66Met polymorphism of the brain-derived neurotrophic factor in fibromyalgia. Adv Rheumatol 60(39), 2020. https://doi.org/10.1186/ s42358-020-00141-9</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_2y4ZAEF">Sex differences in pain: A brief review of clinical and experimental findings</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Bartley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Fillingim</surname></persName>
		</author>
		<idno type="DOI">10.1093/bja/aet127</idno>
		<ptr target="https://doi.org/10.1093/bja/aet127" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_zA9Dqyj">Br J Anaesth</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="52" to="58" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bartley EJ, Fillingim RB: Sex differences in pain: A brief review of clinical and experimental findings. Br J Anaesth 111:52-58, 2013. https://doi.org/10.1093/bja/aet127</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_g4jAgze">Validation of the Brazilian Portuguese version of the Pittsburgh Sleep Quality Index</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Bertolazi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Fagondes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Hoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Dartora</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">C</forename><surname>Miozzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>De Barba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Barreto</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.sleep.2010.04.020</idno>
		<ptr target="https://doi.org/10.1016/j.sleep.2010.04.020" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_2cbBm3X">Sleep Med</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="70" to="75" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bertolazi AN, Fagondes SC, Hoff LS, Dartora EG, Miozzo IC, de Barba ME, Barreto SS: Validation of the Brazilian Por- tuguese version of the Pittsburgh Sleep Quality Index. Sleep Med 12:70-75, 2011. https://doi.org/10.1016/j.sleep.2010.04. 020</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_7UwCjqZ">Transcranial direct current stimulation does not counteract cognitive fatigue, but induces sleepiness and an inter-hemispheric shift in brain oxygenation</title>
		<author>
			<persName><forename type="first">G</forename><surname>Borrag An</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Guerrero-Mosquera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Di</forename><surname>Ricci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Slama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Peigneux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
		<idno type="DOI">10.3389/fpsyg.2018.02351</idno>
		<ptr target="https://doi.org/10.3389/fpsyg.2018.02351.2351" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_8HbmTp2">Front Psychol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">9</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Borrag an G, Gilson M, Guerrero-Mosquera C, Di Ricci E, Slama H, Peigneux P: Transcranial direct current stimulation does not counteract cognitive fatigue, but induces sleepi- ness and an inter-hemispheric shift in brain oxygenation. Front Psychol 30:9, 2018. https://doi.org/10.3389/fpsyg. 2018.02351. 2351</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_CNK7wTn">Potency of descending pain modulatory system is linked with peripheral sensory dysfunction in fibromyalgia: An exploratory study</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Brietzke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Antunes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Carvalho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Elkifury</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gasparin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Prs</forename><surname>Sanches</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Silva</forename><surname>Da</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Junior</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Duss An-Sarria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Silva</forename><surname>Da</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">L</forename><surname>Torres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fregni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Md</surname></persName>
		</author>
		<idno type="DOI">10.1097/md.0000000000013477</idno>
		<ptr target="https://doi.org/10.1097/MD.0000000000013477" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_tZhQQgV">Medicine</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page">13477</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Brietzke AP, Antunes LC, Carvalho F, Elkifury J, Gasparin A, Sanches PRS, da Silva Junior DP, Duss an-Sarria JA, Souza A, da Silva Torres IL, Fregni F, Md WC: Potency of descend- ing pain modulatory system is linked with peripheral sen- sory dysfunction in fibromyalgia: An exploratory study. Medicine 98:e13477, 2019. https://doi.org/10.1097/MD. 0000000000013477</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_eWq4tsb">Large treatment effect with extended home-based transcranial direct current stimulation over dorsolateral prefrontal cortex in fibromyalgia: A proof of concept Sham-Randomized Clinical Study</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Brietzke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zortea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Carvalho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Prs</forename><surname>Sanches</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dpj</forename><surname>Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ilds</forename><surname>Torres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fregni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Caumo</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jpain.2019.06.013</idno>
		<ptr target="https://doi.org/10.1016/j.jpain.2019.06.013" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_sgC256c">J Pain</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="212" to="224" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Brietzke AP, Zortea M, Carvalho F, Sanches PRS, Silva DPJ, Torres ILDS, Fregni F, Caumo W: Large treatment effect with extended home-based transcranial direct current stim- ulation over dorsolateral prefrontal cortex in fibromyalgia: A proof of concept Sham-Randomized Clinical Study. J Pain 21:212-224, 2020. https://doi.org/10.1016/j.jpain.2019.06. 013</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_fjqmM3D">Trial of electrical directcurrent therapy versus escitalopram for depression</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Brunoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Moffa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Sampaio-Junior</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Borrione</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fernandes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Veronezi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Nogueira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Aparicio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Razza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Chamorro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tort</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fraguas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lotufo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Gattaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fregni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Benseñor</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmoa1612999</idno>
		<ptr target="https://doi.org/10.1056/NEJMoa1612999" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_eAqKMYr">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">376</biblScope>
			<biblScope unit="page" from="2523" to="2533" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Brunoni AR, Moffa AH, Sampaio-Junior B, Borrione L, Moreno M, Fernandes R, Veronezi B, Nogueira B, Aparicio L, Razza L, Chamorro R, Tort L, Fraguas R, Lotufo P, Gattaz W, Fregni F, Benseñor I: Trial of electrical direct- current therapy versus escitalopram for depression. N Engl J Med 376:2523-2533, 2017. https://doi.org/10.1056/ NEJMoa1612999</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_dHCXGun">BDNF blood levels after non-invasive brain stimulation interventions in major depressive disorder: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Brunoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Baeken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Machado-Vieira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">F</forename><surname>Gattaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Vanderhasselt</surname></persName>
		</author>
		<idno type="DOI">10.3109/15622975.2014.958101</idno>
		<ptr target="https://doi.org/10.3109/15622975.2014.958101" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_hsRBY3c">World J. Biol. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="114" to="122" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Brunoni AR, Baeken C, Machado-Vieira R, Gattaz WF, Vanderhasselt MA: BDNF blood levels after non-invasive brain stimulation interventions in major depressive disor- der: a systematic review and meta-analysis. World J. Biol. Psychiatry 16:114-122, 2015. https://doi.org/10.3109/ 15622975.2014.958101</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_aYE4gQ9">Home-based transcranial direct current stimulation device development: An updated protocol used at home in healthy subjects and fibromyalgia patients</title>
		<author>
			<persName><forename type="first">F</forename><surname>Carvalho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Brietzke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gasparin</surname></persName>
		</author>
		<author>
			<persName><surname>Fp Dos Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Vercelino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Ballester</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Prs</forename><surname>Sanches</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jr</forename><surname>Da Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Torres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ils</forename><surname>Fregni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Caumo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename></persName>
		</author>
		<idno type="DOI">10.3791/57614</idno>
		<ptr target="https://doi.org/10.3791/57614" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_TrKMzTU">J Vis Exp</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="page">57614</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Carvalho F, Brietzke AP, Gasparin A, FP Dos Santos, Ver- celino R, Ballester RF, Sanches PRS, Jr da Silva DP, Torres ILS, Fregni F, Caumo W: Home-based transcranial direct current stimulation device development: An updated protocol used at home in healthy subjects and fibromyalgia patients. J Vis Exp 137:57614, 2018. https://doi.org/10.3791/57614</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_ESjTEUU">The Central Sensitization Inventory validated and adapted for a Brazilian population: Psychometric properties and its relationship with brain-derived neurotrophic factor</title>
		<author>
			<persName><forename type="first">W</forename><surname>Caumo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Antunes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Elkfury</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Herbstrith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Busanello</forename><surname>Sipmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Torres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">L</forename><surname>Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dos</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Neblett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
		<idno type="DOI">10.2147/jpr.s131479</idno>
		<ptr target="https://doi.org/10.2147/JPR.S131479" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_nhffU7Y">J Pain Res</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="2109" to="2122" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Caumo W, Antunes LC, Elkfury JL, Herbstrith EG, Busa- nello Sipmann R, Souza A, Torres IL, Souza Dos Santos V, Neblett R: The Central Sensitization Inventory validated and adapted for a Brazilian population: Psychometric prop- erties and its relationship with brain-derived neurotrophic factor. J Pain Res 10:2109-2122, 2017. https://doi.org/ 10.2147/JPR.S131479</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_cfYyPmc">Torres ILS: Cross-cultural adaptation and validation of the profile of chronic pain: Screen for a Brazilian population</title>
		<author>
			<persName><forename type="first">W</forename><surname>Caumo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Ruehlman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Karoly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Sehn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Vidor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Dall-Agnol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chassot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Iraci</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1526-4637.2012.01528.x</idno>
		<ptr target="https://doi.org/10.1111/j.1526-4637.2012.01528.x" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_AFA8mF4">Pain Med</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="52" to="61" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Caumo W, Ruehlman LS, Karoly P, Sehn F, Vidor LP, Dall- Agnol L, Chassot M, Iraci LS, Torres ILS: Cross-cultural adaptation and validation of the profile of chronic pain: Screen for a Brazilian population. Pain Med 14:52-61, 2013. https://doi.org/10.1111/j.1526-4637.2012.01528.x</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_837TGgq">The dorsolateral prefrontal cortex in acute and chronic pain</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Seminowicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Moayed</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jpain.2017.03.008</idno>
		<ptr target="https://doi.org/10.1016/j.jpain.2017.03.008" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_RNgB4Rb">J Pain</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="1027" to="1035" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Seminowicz DA, Moayed M: The dorsolateral prefron- tal cortex in acute and chronic pain. J Pain 18:1027-1035, 2017. https://doi.org/10.1016/j.jpain.2017.03.008</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_rfuJx4t">Transcranial direct current stimulation in the modulation of neuropathic pain: A systematic review</title>
		<author>
			<persName><forename type="first">Mcmm</forename><surname>David</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Moraes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mld</forename><surname>Costa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cif</forename><surname>Franco</surname></persName>
		</author>
		<idno type="DOI">10.1080/01616412.2018.1453190</idno>
		<ptr target="https://doi.org/10.1080/01616412.2018.1453190" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_eqB2vhP">Neurol Res</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="555" to="563" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">David MCMM, Moraes AA, Costa MLD, Franco CIF: Transcranial direct current stimulation in the modulation of neuropathic pain: A systematic review. Neurol Res 40:555- 563, 2018. https://doi.org/10.1080/01616412.2018.1453190</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_BeF3NJn">Enhancement of pain inhibition by working memory with anodal transcranial direct current stimulation of the left dorsolateral prefrontal cortex</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Deldar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Rustamov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bois</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Blanchette</surname></persName>
		</author>
		<author>
			<persName><surname>Pich E M</surname></persName>
		</author>
		<idno type="DOI">10.1007/s12576-018-0598-4</idno>
		<ptr target="https://doi.org/10.1007/s12576-018-0598-4" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_pY8M23Z">J Physiol Sci</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="825" to="836" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Deldar Z, Rustamov N, Bois S, Blanchette I, Pich e M: Enhancement of pain inhibition by working memory with anodal transcranial direct current stimulation of the left dorsolateral prefrontal cortex. J Physiol Sci 68:825-836, 2018. https://doi.org/10.1007/s12576-018-0598-4</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_w2Yhyxb">Emotion, and the prefrontal cortex: An integrative review</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Dixon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Thiruchselvam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Todd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Christoff</surname></persName>
		</author>
		<idno type="DOI">10.1037/bul0000096</idno>
		<ptr target="https://doi.org/10.1037/bul0000096" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_B8yh39P">Psychol Bull</title>
		<imprint>
			<biblScope unit="volume">143</biblScope>
			<biblScope unit="page" from="1033" to="1081" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dixon ML, Thiruchselvam R, Todd R, Christoff K: Emo- tion, and the prefrontal cortex: An integrative review. Psy- chol Bull 143:1033-1081, 2017. https://doi.org/10.1037/ bul0000096</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_dHEAbk2">Catastrophizing interferes with cognitive modulation of pain in women with fibromyalgia</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Ellingson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Stegner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Schwabacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Lindheimer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Cook</surname></persName>
		</author>
		<idno type="DOI">10.1093/pm/pny008</idno>
		<ptr target="https://doi.org/10.1093/pm/pny008" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_MftnjHv">Pain Med</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="2408" to="2422" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ellingson LD, Stegner AJ, Schwabacher IJ, Lindheimer JB, Cook DB: Catastrophizing interferes with cognitive modulation of pain in women with fibromyalgia. Pain Med 19:2408-2422, 2018. https://doi.org/10.1093/pm/pny008</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_Edm6NvU">Regulatory considerations for the clinical and research use of transcranial direct current stimulation (tDCS): Review and recommendations from an expert panel</title>
		<author>
			<persName><forename type="first">F</forename><surname>Fregni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Nitsche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Loo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Brunoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Marangolo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Leite</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Carvalho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bolognini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Caumo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Paik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Simis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ueda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ekhtiari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Luu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Tucker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Tyler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Brunelin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Datta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Juan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Venkatasubramanian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Boggio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Bikson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<idno type="DOI">10.3109/10601333.2015.980944</idno>
		<ptr target="https://doi.org/10.3109/10601333.2015.980944.1060-1333(print)(elec-tronic)" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_PSWRCYU">Clin Res Regul Aff</title>
		<imprint>
			<biblScope unit="volume">1532</biblScope>
			<biblScope unit="issue">2521</biblScope>
			<biblScope unit="page">201446</biblScope>
		</imprint>
	</monogr>
	<note type="raw_reference">Fregni F, Nitsche MA, Loo CK, Brunoni AR, Marangolo P, J. Leite J, Carvalho S, Bolognini N, Caumo W, Paik NJ, M. Simis M, Ueda K, Ekhtiari H, Luu P, Tucker DM, Tyler WJ, Brunelin J, Datta A, Juan CH, Venkatasubramanian G, Bog- gio PS, Bikson M: Regulatory considerations for the clinical and research use of transcranial direct current stimulation (tDCS): Review and recommendations from an expert panel. Clin Res Regul Aff 1532-2521, 201446#. https://doi. org/10.3109/10601333.2015.980944. 1060-1333 (print)(elec- tronic)</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_YtYpMZh">Direct current stimulation promotes BDNFdependent synaptic plasticity: potential implications for motor learning</title>
		<author>
			<persName><forename type="first">B</forename><surname>Fritsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Reis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Martinowich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Schambra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lu</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuron.2010.03.035</idno>
		<ptr target="https://doi.org/10.1016/j.neuron.2010.03.035" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_XtZD88U">Neuron</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="198" to="204" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fritsch B, Reis J, Martinowich K, Schambra HM, Ji Y, Cohen LG, Lu B: Direct current stimulation promotes BDNF- dependent synaptic plasticity: potential implications for motor learning. Neuron 66:198-204, 2010. https://doi.org/ 10.1016/j.neuron.2010.03.035</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_jC6mHNq">A systematic review of structural and functional MRI studies on pain catastrophizing</title>
		<author>
			<persName><forename type="first">A</forename><surname>Galambos</surname></persName>
		</author>
		<author>
			<persName><surname>Szab O E</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Nagy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Edes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kocsel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Juh Asz</surname></persName>
		</author>
		<idno type="DOI">10.2147/jpr.s192246</idno>
		<ptr target="https://doi.org/10.2147/JPR.S192246" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_CWdYh4p">J Pain Res</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1155" to="1178" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Galambos A, Szab o E, Nagy Z, Edes AE, Kocsel N, Juh asz G, K€ ok€ onyei G: A systematic review of structural and func- tional MRI studies on pain catastrophizing. J Pain Res 11:1155-1178, 2019. https://doi.org/10.2147/JPR.S192246</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_XcrnbU7">Transcranial DC stimulation (tDCS): A tool for double-blind sham-controlled clinical studies in brain stimulation</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Gandiga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Hummel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Cohen</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.clinph.2005.12.003</idno>
		<ptr target="https://doi.org/10.1016/j.clinph.2005.12.003" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_WtrfY9E">Clin Neurophysiol</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="845" to="850" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gandiga PC, Hummel FC, Cohen LG: Transcranial DC stimulation (tDCS): A tool for double-blind sham-controlled clinical studies in brain stimulation. Clin Neurophysiol 117:845-850, 2006. https://doi.org/10.1016/j.clinph.2005.12. 003</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_qveJrqV">Brain-derived neurotrophic factor modulates the effect of sex on the descending pain modulatory system in healthy volunteers</title>
		<author>
			<persName><forename type="first">A</forename><surname>Gasparin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zortea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dos</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">S</forename><surname>Carvalho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Torres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ils</forename><surname>De Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fregni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Caumo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename></persName>
		</author>
		<idno type="DOI">10.1093/pm/pnaa027</idno>
		<ptr target="https://doi.org/10.1093/pm/pnaa027" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_ktSuBMg">Pain Med</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="2271" to="2279" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gasparin A, Zortea M, Dos Santos VS, Carvalho F, Torres ILS, de Souza A, Fregni F, Caumo W: Brain-derived neuro- trophic factor modulates the effect of sex on the descending pain modulatory system in healthy volunteers. Pain Med 21:2271-2279, 2020. https://doi.org/10.1093/pm/ pnaa027</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_xujMuNn">Neural mechanisms of cognitive reappraisal of negative self-beliefs in social anxiety disorder</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Goldin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Manber-Ball</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Werner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Heimberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Gross</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.biopsych.2009.07.014</idno>
		<ptr target="https://doi.org/10.1016/j.biopsych.2009.07.014" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_29pStVs">Biol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="1091" to="1099" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Goldin PR, Manber-Ball T, Werner K, Heimberg R, Gross JJ: Neural mechanisms of cognitive reappraisal of negative self-beliefs in social anxiety disorder. Biol Psychiatry 66:1091- 1099, 2009. https://doi.org/10.1016/j.biopsych.2009.07.014</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_RBpCSqR">Validation of the Brazilian Portuguese version of the Beck Depression Inventory-II in a community sample</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Gomes-Oliveira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gorenstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lotufo</forename><surname>Neto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Andrade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">P</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.rbp.2012.03.005</idno>
		<ptr target="https://doi.org/10.1016/j.rbp.2012.03.005" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_WJu2Vgz">Braz J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="389" to="394" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gomes-Oliveira MH, Gorenstein C, Lotufo Neto F, Andrade LH, Wang YP: Validation of the Brazilian Portu- guese version of the Beck Depression Inventory-II in a com- munity sample. Braz J Psychiatry 34:389-394, 2012. https:// doi.org/10.1016/j.rbp.2012.03.005</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_rBJXjT2">Imbalance between left and right dorsolateral prefrontal cortex in major depression is linked to negative emotional judgment: An fMRI study in severe major depressive disorder</title>
		<author>
			<persName><forename type="first">S</forename><surname>Grimm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Schuepbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Boesiger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bermpohl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Niehaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Boeker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Northoff</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.biopsych.2007.05.033</idno>
		<ptr target="https://doi.org/10.1016/j.biopsych.2007.05.033" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_E5pNNu7">Biol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="369" to="376" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Grimm S, Beck J, Schuepbach D, Hell D, Boesiger P, Bermpohl F, Niehaus L, Boeker H, Northoff G: Imbalance between left and right dorsolateral prefrontal cortex in major depression is linked to negative emotional judg- ment: An fMRI study in severe major depressive disorder. Biol Psychiatry 63:369-376, 2008. https://doi.org/10.1016/j. biopsych.2007.05.033</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_5ckWTzp">Reducing transcranial direct current stimulation-induced erythema with skin pretreatment: considerations for shamcontrolled clinical trials</title>
		<author>
			<persName><forename type="first">F</forename><surname>Guarienti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Caumo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Shiozawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Cordeiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Boggio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Benseñor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Lotufo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bikson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Brunoni</surname></persName>
		</author>
		<idno type="DOI">10.1111/ner.12230</idno>
		<ptr target="https://doi.org/10.1111/ner.12230" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_VNUbQD8">Neuromodulation</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="261" to="265" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Guarienti F, Caumo W, Shiozawa P, Cordeiro Q, Boggio PS, Benseñor IM, Lotufo PA, Bikson M, Brunoni AR: Reduc- ing transcranial direct current stimulation-induced ery- thema with skin pretreatment: considerations for sham- controlled clinical trials. Neuromodulation 18:261-265, 2015. https://doi.org/10.1111/ner.12230</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_jU6jBsB">Sex-based differences in brain alterations across chronic pain conditions</title>
		<author>
			<persName><forename type="first">A</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Mayer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Labus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Naliboff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lisa</forename><forename type="middle">A</forename><surname>Kilpatrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename></persName>
		</author>
		<idno type="DOI">10.1002/jnr.23856</idno>
		<ptr target="https://doi.org/10.1002/jnr.23856" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_j2c8B8W">J Neurosci Res</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="604" to="616" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gupta A, Mayer EA, Fling C, Labus JS, Naliboff BD, Hong J, Lisa A, Kilpatrick LA: Sex-based differences in brain alterations across chronic pain conditions. J Neurosci Res 95:604-616, 2017. https://doi.org/10.1002/jnr.23856</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_Xux3bkP">The neurobiology of central sensitization</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Harte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Clauw</surname></persName>
		</author>
		<idno type="DOI">10.1111/jabr.12137</idno>
		<ptr target="https://doi.org/10.1111/jabr.12137" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_Sr9rfeg">J Appl Behav Res</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page">12137</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Harte SE, Harris RE, Clauw DJ: The neurobiology of cen- tral sensitization. J Appl Behav Res 23:e12137, 2018. https:// doi.org/10.1111/jabr.12137</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_ahVcUys">Topographic organization of corticospinal projections from the frontal lobe: Motor areas on the lateral surface of the hemisphere</title>
		<author>
			<persName><forename type="first">S</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Dum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Strick</surname></persName>
		</author>
		<idno type="DOI">10.1523/jneurosci.13-03-00952.1993</idno>
		<ptr target="https://doi.org/10.1523/JNEUROSCI.13-03-00952.1993" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_qRe722A">J Neurosci</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="952" to="980" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
	<note type="raw_reference">He S, Dum RP, Strick PL: Topographic organization of corticospinal projections from the frontal lobe: Motor areas on the lateral surface of the hemisphere. J Neurosci 13:952-980, 1993. https://doi.org/10.1523/JNEUROSCI.13-03- 00952.1993</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_x9FNvjH">Modulating the pain network-Neurostimulation for central poststroke pain</title>
		<author>
			<persName><forename type="first">K</forename><surname>Hosomi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Seymour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Saitoh</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrneurol.2015.58</idno>
		<ptr target="https://doi.org/10.1038/nrneurol.2015.58" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_2WWUest">Nat Rev Neurol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="290" to="299" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hosomi K, Seymour B, Saitoh Y: Modulating the pain network-Neurostimulation for central poststroke pain. Nat Rev Neurol 11:290-299, 2015. https://doi.org/10.1038/ nrneurol.2015.58</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_nzNUsX6">Neuroinflammation and central sensitization in chronic and widespread pain</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Ji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nackley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Huh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Terrando</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Maixner</surname></persName>
		</author>
		<idno type="DOI">10.1097/aln.0000000000002130</idno>
		<ptr target="https://doi.org/10.1097/ALN.0000000000002130" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_wmCvj2G">Anesthesiology</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page" from="343" to="366" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ji RR, Nackley A, Huh Y, Terrando N, Maixner W: Neuro- inflammation and central sensitization in chronic and wide- spread pain. Anesthesiology 129:343-366, 2018. https://doi. org/10.1097/ALN.0000000000002130</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_UGa7kKH">Evaluation of the structure of Brazilian State-Trait Anxiety Inventory using a Rasch psychometric approach</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Kaipper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Chachamovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Hidalgo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">L</forename><surname>Torres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Caumo</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jpsychores.2009.09.013</idno>
		<ptr target="https://doi.org/10.1016/j.jpsychores.2009.09.013" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_CQVuM9C">J Psychosom Res</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="223" to="233" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kaipper MB, Chachamovich E, Hidalgo MP, Torres IL, Caumo W: Evaluation of the structure of Brazilian State- Trait Anxiety Inventory using a Rasch psychometric approach. J Psychosom Res 68:223-233, 2010. https://doi. org/10.1016/j.jpsychores.2009.09.013</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_UPZkKd8">Effect sizes for interpreting changes in health status</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Kazis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Meenan</surname></persName>
		</author>
		<idno type="DOI">10.1097/00005650-198903001-00015</idno>
		<ptr target="https://doi.org/10.1097/00005650-198903001-00015" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_YPtJRg6">Med Care</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="178" to="S189" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kazis LE, Anderson JJ, Meenan RF: Effect sizes for inter- preting changes in health status. Med Care 27:S178-S189, 1989. https://doi.org/10.1097/00005650-198903001-00015</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_ExR3zWK">A key factor with multipotent impact on brain signaling and synaptic plasticity</title>
		<author>
			<persName><forename type="first">P</forename><surname>Kowia Nski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lietzau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Czuba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wa Skow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Steliga</surname></persName>
		</author>
		<author>
			<persName><surname>Mory S Jbdnf</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10571-017-0510-4</idno>
		<ptr target="https://doi.org/10.1007/s10571-017-0510-4" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_FCpKdh9">Cell Mol Neurobiol</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="579" to="593" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kowia nski P, Lietzau G, Czuba E, Wa skow M, Steliga A, Mory s JBDNF: A key factor with multipotent impact on brain signaling and synaptic plasticity. Cell Mol Neurobiol 38:579-593, 2018. https://doi.org/10.1007/s10571-017-0510- 4</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_GKzVYRm">Nabiximols for the treatment of cannabis dependence: A Randomized Clinical Trial</title>
		<author>
			<persName><forename type="first">N</forename><surname>Lintzeris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bhardwaj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mills</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dunlop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Copeland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Mcgrego</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bruno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gugusheff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Phung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Montebello</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kirby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jefferies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Luksza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Shanahan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kevin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Allsop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2019.1993</idno>
		<ptr target="https://doi.org/10.1001/jamainternmed.2019.1993" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_vkmqndg">JAMA Intern Med</title>
		<imprint>
			<biblScope unit="volume">179</biblScope>
			<biblScope unit="page" from="1242" to="1253" />
			<date type="published" when="2019-07-15">2019 Jul 15. 2019</date>
		</imprint>
	</monogr>
	<note>online ahead of print</note>
	<note type="raw_reference">Lintzeris N, Bhardwaj A, Mills L, Dunlop A, Copeland J, McGrego I, Bruno R, Gugusheff J, Phung N, Montebello Chan T, Kirby A, Hall M, Jefferies M, Luksza J, Shanahan M, Kevin R, Allsop D: Nabiximols for the treatment of cannabis dependence: A Randomized Clinical Trial [published online ahead of print, 2019 Jul 15]. JAMA Intern Med 179:1242-1253, 2019. https://doi.org/10.1001/ jamainternmed.2019.1993</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_yQ8qcJt">Keeping pain out of mind: The role of the dorsolateral prefrontal cortex in pain modulation</title>
		<author>
			<persName><forename type="first">J</forename><surname>Lorenz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Minoshima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Casey</surname></persName>
		</author>
		<idno type="DOI">10.1093/brain/awg102</idno>
		<ptr target="https://doi.org/10.1093/brain/awg102" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_PcFp6jA">Brain</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="1079" to="1091" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lorenz J, Minoshima S, Casey KL: Keeping pain out of mind: The role of the dorsolateral prefrontal cortex in pain modulation. Brain 126:1079-1091, 2003. https://doi.org/ 10.1093/brain/awg102</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_uWDuQY4">Neurobiological effects of transcranial direct current stimulation: a review</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Medeiros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">C</forename><surname>De Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Vidor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>De Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Deitos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Volz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fregni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Caumo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">L</forename><surname>Torres</surname></persName>
		</author>
		<idno type="DOI">10.3389/fpsyt.2012.00110</idno>
		<ptr target="https://doi.org/10.3389/fpsyt.2012.00110" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_g8a4EQs">Front Psychiatry</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">110</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Medeiros LF, de Souza IC, Vidor LP, de Souza A, Deitos A, Volz MS, Fregni F, Caumo W, Torres IL: Neurobiological effects of transcranial direct current stimulation: a review. Front Psychiatry 3:110, 2012. https://doi.org/10.3389/ fpsyt.2012.00110</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_2mdGw5u">Statistical significant change versus relevant or important change in (quasi) experimental design: Some conceptual and methodological problems in estimating magnitude of intervention-related change in health services research</title>
		<author>
			<persName><forename type="first">B</forename><surname>Middel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Van Sonderen</surname></persName>
		</author>
		<idno type="DOI">10.5334/ijic.65</idno>
		<ptr target="https://doi.org/10.5334/ijic.65" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_NkSTJkq">Int J Integr Care</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">15</biblScope>
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Middel B, van Sonderen E: Statistical significant change versus relevant or important change in (quasi) experimental design: Some conceptual and methodological problems in estimating magnitude of intervention-related change in health services research. Int J Integr Care 2:e15, 2002. https://doi.org/10.5334/ijic.65</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_XrEfRwU">The cortical topography of local sleep</title>
		<author>
			<persName><forename type="first">M</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Huber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Esser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Riedner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Massimini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ferrarelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Ghilardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tononi</surname></persName>
		</author>
		<idno type="DOI">10.2174/156802611797470303</idno>
		<ptr target="https://doi.org/10.2174/156802611797470303" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_GkGWWts">Curr Top Med Chem</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="2438" to="2446" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Murphy M, Huber R, Esser S, Riedner BA, Massimini M, Ferrarelli F, Ghilardi MF, Tononi G: The cortical topography of local sleep. Curr Top Med Chem 11:2438-2446, 2011. https://doi.org/10.2174/156802611797470303</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_JTHV7we">Source modeling sleep slow waves</title>
		<author>
			<persName><forename type="first">M</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Riedner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Huber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Massimini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ferrarelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tononi</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.0807933106</idno>
		<ptr target="https://doi.org/10.1073/pnas.0807933106" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_QXqenjG">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="1608" to="1613" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Murphy M, Riedner BA, Huber R, Massimini M, Ferrar- elli F, Tononi G: Source modeling sleep slow waves. Proc Natl Acad Sci U S A 106:1608-1613, 2009. https://doi.org/ 10.1073/pnas.0807933106</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_hYg8Gku">Effects of transcranial direct current stimulation on pain perception and working memory</title>
		<author>
			<persName><forename type="first">V</forename><surname>Mylius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Menzler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Haag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Khader</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Oertel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Rosenow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Lefaucheur</surname></persName>
		</author>
		<idno type="DOI">10.1093/brain/awg102</idno>
		<ptr target="https://doi.org/10.1093/brain/awg102" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_jR55W92">Eur J Pain</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="974" to="982" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mylius V, Jung M, Menzler K, Haag A, Khader PH, Oer- tel WH, Rosenow F, Lefaucheur JP: Effects of transcranial direct current stimulation on pain perception and working memory. Eur J Pain 16:974-982, 2012. https://doi.org/ 10.1093/brain/awg102</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_AhGyDxT">The Central Sensitization Inventory (CSI): Establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample</title>
		<author>
			<persName><forename type="first">R</forename><surname>Neblett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Hartzell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Mayer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Gatchel</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jpain.2012.11.012</idno>
		<ptr target="https://doi.org/10.1016/j.jpain.2012.11.012" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_VddFSqP">J Pain</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="438" to="445" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Neblett R, Cohen H, Choi Y, Hartzell MM, Williams M, Mayer TG, Gatchel RJ: The Central Sensitization Inventory (CSI): Establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample. J Pain 14:438-445, 2013. https://doi.org/10.1016/j. jpain.2012.11.012</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_52P52VF">IASP taskforce for the classification of chronic pain. The IASP classification of chronic pain for ICD-11: Chronic primary pain</title>
		<author>
			<persName><forename type="first">M</forename><surname>Nicholas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jws</forename><surname>Vlaeyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Rief</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Barke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Aziz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Benoliel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Evers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Giamberardino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Goebel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Korwisi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Perrot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Svensson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Treede</surname></persName>
		</author>
		<idno type="DOI">10.1097/j.pain.0000000000001390</idno>
		<ptr target="https://doi.org/10.1097/j.pain.0000000000001390" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_KYUQrGN">Pain</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="page" from="28" to="37" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nicholas M, Vlaeyen JWS, Rief W, Barke A, Aziz Q, Benoliel R, Cohen M, Evers S, Giamberardino MA, Goebel A, Korwisi B, Perrot S, Svensson P, Wang SJ, Treede RD: IASP taskforce for the classification of chronic pain. The IASP classification of chronic pain for ICD-11: Chronic primary pain. Pain. 160:28-37, 2019. https://doi.org/10.1097/j. pain.0000000000001390</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_NnaYpvr">Treatment of depression with transcranial direct current stimulation (tDCS): A Review</title>
		<author>
			<persName><forename type="first">Nitsche</forename><surname>Michael</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Boggio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Fregni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Pascual-Leone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.expneurol.2009.03.038</idno>
		<ptr target="https://doi.org/10.1016/j.expneurol.2009.03.038" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_NtefSX4">Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">219</biblScope>
			<biblScope unit="page" from="14" to="19" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nitsche Michael A, Boggio PS, Fregni F, Pascual-Leone A: Treatment of depression with transcranial direct current stimulation (tDCS): A Review. Exp Neurol 219:14-19, 2009. https://doi.org/10.1016/j.expneurol.2009.03.038</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main" xml:id="_Sk2qyjF">Modulation of emotions associated with images of human pain using anodal transcranial direct current stimulation (tDCS)</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Boggio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zaghi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fregni</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuropsychologia.2008.07.022</idno>
		<ptr target="https://doi.org/10.1016/j.neuropsychologia.2008.07.022" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_zWnKeTh">Neuropsychologia</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="212" to="217" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Boggio PS, Zaghi S, Fregni F: Modulation of emotions associated with images of human pain using anodal transcranial direct current stimulation (tDCS). Neuropsycho- logia 47:212-217, 2009. https://doi.org/10.1016/j. neuropsychologia.2008.07.022</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_QZ8maMK">Down-regulation of negative emotional processing by transcranial direct current stimulation: effects of personality characteristics</title>
		<author>
			<persName><forename type="first">C</forename><surname>Pena-Gomez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Vidal-Pineiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">C</forename><surname>Clemente</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pascual-Leone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bartres-Faz</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0022812</idno>
		<ptr target="https://doi.org/10.1371/journal.pone.0022812" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_USUcF8M">PloS One</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">22812</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pena-Gomez C, Vidal-Pineiro D, Clemente IC, Pasc- ual-Leone A, Bartres-Faz D: Down-regulation of negative emotional processing by transcranial direct current stim- ulation: effects of personality characteristics. PloS One 6: e22812, 2011. https://doi.org/10.1371/journal.pone. 0022812</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main" xml:id="_DPTeuTz">Preoperative transcranial direct current stimulation: Exploration of a novel strategy to enhance neuroplasticity before surgery to control postoperative pain. A randomized sham-controlled study</title>
		<author>
			<persName><forename type="first">H</forename><surname>Ribeiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Sesterhenn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Alves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Machado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">B</forename><surname>Burger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ilds</forename><surname>Torres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Stefani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fregni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Caumo</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0187013</idno>
		<ptr target="https://doi.org/10.1371/journal.pone.0187013" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_pGYps7y">PLoS One</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">187013</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ribeiro H, Sesterhenn RB, Souza A, Souza AC, Alves M, Machado JC, Burger NB, Torres ILDS, Stefani LC, Fregni F, Caumo W: Preoperative transcranial direct current stimula- tion: Exploration of a novel strategy to enhance neuroplas- ticity before surgery to control postoperative pain. A randomized sham-controlled study. PLoS One 12:e0187013, 2017. https://doi.org/10.1371/journal.pone.0187013</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main" xml:id="_QDdEsg5">Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Rybakowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Borkowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Czerski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Skibinska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hauser</surname></persName>
		</author>
		<idno type="DOI">10.1590/S1516-44462009000200010</idno>
		<ptr target="https://doi.org/10.1590/S1516-44462009000200010" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_EWsa8w7">Bipolar Disord</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="468" to="472" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rybakowski JK, Borkowska A, Czerski PM, Skibinska M, Hauser J: Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disord 5:468-472, 2003. https:// doi.org/10.1590/S1516-44462009000200010</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main" xml:id="_kzhRjEW">Cellular circuits in the brain and their modulation in acute and chronic pain</title>
		<author>
			<persName><forename type="first">Kuner</forename><surname>Rohini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Kuner</forename><surname>Thomas</surname></persName>
		</author>
		<idno type="DOI">10.1152/physrev.00040.2019</idno>
		<ptr target="https://doi.org/10.1152/physrev.00040.2019" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_BBkR68W">Physiol Rev</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="213" to="258" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kuner Rohini, Kuner Thomas: Cellular circuits in the brain and their modulation in acute and chronic pain. Physiol Rev 101:213-258, 2021. https://doi.org/10.1152/physrev.00040.2019</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main" xml:id="_UxrKECT">Transcranial direct current stimulation targeting primary motor versus dorsolateral prefrontal cortices: Proof-of-Concept Study Investigating functional connectivity of Thalamocortical Networks specific to sensoryaffective information processing</title>
		<author>
			<persName><forename type="first">V</forename><surname>Sankarasubramanian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Cunningham</surname></persName>
		</author>
		<author>
			<persName><surname>Ka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Beall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Roelle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Varnerin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Machado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mark</forename><forename type="middle">J</forename><surname>Lowe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Plow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename></persName>
		</author>
		<idno type="DOI">10.1089/brain.2016.0440</idno>
		<ptr target="https://doi.org/10.1089/brain.2016.0440" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_P92JjDD">Brain Connect</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="182" to="196" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sankarasubramanian V, Cunningham DA KA, Beall EB, Roelle SM, Varnerin NM, Machado AG, Jones SE, Mark J Lowe MJ, Plow EB: Transcranial direct current stimulation targeting primary motor versus dorsolateral prefrontal cor- tices: Proof-of-Concept Study Investigating functional con- nectivity of Thalamocortical Networks specific to sensory- affective information processing. Brain Connect 7:182-196, 2017. https://doi.org/10.1089/brain.2016.0440</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main" xml:id="_ebC9fFn">Cognitive effects of transcranial direct current stimulation combined with working memory training in fibromyalgia: A randomized clinical trial</title>
		<author>
			<persName><forename type="first">Vsdsd</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zortea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Alves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ccds</forename><surname>Naziazeno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Saldanha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Sdcr</forename><surname>Carvalho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ajdc</forename><surname>Leite</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ilds</forename><surname>Torres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P € U</forename><surname>Calvetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fregni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Caumo</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41598-018-30127-z</idno>
		<ptr target="https://doi.org/10.1038/s41598-018-30127-z" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_xSrHgeZ">Sci Rep</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">12477</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Santos VSDSD, Zortea M, Alves RL, Naziazeno CCDS, Sal- danha JS, Carvalho SDCR, Leite AJDC, Torres ILDS, Souza A, Calvetti P € U, Fregni F, Caumo W: Cognitive effects of trans- cranial direct current stimulation combined with working memory training in fibromyalgia: A randomized clinical trial. Sci Rep 8:12477, 2018. https://doi.org/10.1038/s41598- 018-30127-z</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main" xml:id="_kBqcC5s">Validation of a Brazilian quantitative sensory testing (QST) device for the diagnosis of small fiber neuropathies</title>
		<author>
			<persName><forename type="first">P</forename><surname>Schestatsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Stefani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Sanches</surname></persName>
		</author>
		<author>
			<persName><forename type="first">-J Unior</forename><surname>Sampaio</surname></persName>
		</author>
		<author>
			<persName><surname>Dp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ils</forename><surname>Torres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Dall-Agnol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fachin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Caumo</surname></persName>
		</author>
		<idno type="DOI">10.1590/s0004-282x2011000700019</idno>
		<ptr target="https://doi.org/10.1590/s0004-282x2011000700019" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_5QdPfFP">Arq Neuropsiquiatr</title>
		<imprint>
			<biblScope unit="issue">69</biblScope>
			<biblScope unit="page" from="943" to="948" />
			<date type="published" when="2011">2011. 2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Schestatsky P, Stefani LC, Sanches PR, Sampaio-J unior DP, Torres ILS, Dall-Agnol L, Fachin L, Caumo W: Validation of a Brazilian quantitative sensory testing (QST) device for the diagnosis of small fiber neuropathies. Arq Neuropsi- quiatr 2011(69):943-948, 2011. https://doi.org/10.1590/ s0004-282x2011000700019</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main" xml:id="_46YmGDb">Cross-cultural adaptation and validation of the Brazilian Portuguese version of the pain catastrophizing scale</title>
		<author>
			<persName><forename type="first">F</forename><surname>Sehn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Chachamovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Vidor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Dall-Agnol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">C</forename><surname>De Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">L</forename><surname>Torres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fregni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Caumo</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1526-4637.2012.01492.x</idno>
		<ptr target="https://doi.org/10.1111/j.1526-4637.2012.01492.x" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_TRvtrpv">Pain Med</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="1425" to="1435" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sehn F, Chachamovich E, Vidor LP, Dall-Agnol L, de Souza IC, Torres IL, Fregni F, Caumo W: Cross-cultural adap- tation and validation of the Brazilian Portuguese version of the pain catastrophizing scale. Pain Med 13:1425-1435, 2012. https://doi.org/10.1111/j.1526-4637.2012.01492.x</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main" xml:id="_D9VaQe5">Cortical responses to pain in healthy individuals depends on pain catastrophizing</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Seminowicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Davis</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.pain.2005.11.008</idno>
		<ptr target="https://doi.org/10.1016/j.pain.2005.11.008" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_dqRQuCH">Pain</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="297" to="306" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Seminowicz DA, Davis KD: Cortical responses to pain in healthy individuals depends on pain catastrophizing. Pain 120:297-306, 2006. https://doi.org/10.1016/j.pain.2005.11.008</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main" xml:id="_bT5hhJb">High definitiontranscranial direct current stimulation changes older adults&apos; subjective sleep and corresponding resting-state functional connectivity</title>
		<author>
			<persName><forename type="first">J</forename><surname>Sheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">Q</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Lei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yu</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijpsycho.2018.05.002</idno>
		<ptr target="https://doi.org/10.1016/j.ijpsycho.2018.05.002" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_hYQqJ3r">Int J Psychophysiol</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page" from="1" to="8" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sheng J, Xie C, Fan DQ, Lei X, Yu J: High definition- transcranial direct current stimulation changes older adults&apos; subjective sleep and corresponding resting-state functional connectivity. Int J Psychophysiol 129:1-8, 2018. https://doi. org/10.1016/j.ijpsycho.2018.05.002</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main" xml:id="_GQqPtek">Anodal transcranial direct current stimulation over the left dorsolateral prefrontal cortex modulates attention and pain in fibromyalgia: Randomized clinical trial</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zortea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Carvalho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Leite</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">L</forename><surname>Torres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fregni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Caumo</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41598-017-00185-w</idno>
		<ptr target="https://doi.org/10.1038/s41598-017-00185-w" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_HmR3B99">Sci Rep</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">135</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Silva AF, Zortea M, Carvalho S, Leite J, Torres IL, Fregni F, Caumo W: Anodal transcranial direct current stimulation over the left dorsolateral prefrontal cortex modulates attention and pain in fibromyalgia: Randomized clinical trial. Sci Rep 7:135, 2017. https://doi.org/10.1038/s41598- 017-00185-w</note>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main" xml:id="_HdxE8uY">Mapping of predictors of the disengagement of the descending inhibitory pain modulation system in fibromyalgia: An exploratory study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Soldatelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Siepmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Illigens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dos</forename><surname>Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lucena</forename><surname>Da S Torres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Fregni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Caumo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename></persName>
		</author>
		<idno type="DOI">10.1177/2049463720920760</idno>
		<ptr target="https://doi.org/10.1177/2049463720920760" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_jXARJQj">Br J Pain</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="221" to="233" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Soldatelli MD, Siepmann T, Illigens BM, Souza Dos San- tos V, Lucena da S Torres I, Fregni F, Caumo W: Mapping of predictors of the disengagement of the descending inhibitory pain modulation system in fibromyalgia: An exploratory study. Br J Pain 15:221-233, 2021. https://doi. org/10.1177/2049463720920760</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main" xml:id="_VjKj3fx">Exogenously induced brain activation regulates neuronal activity by top-down modulation: conceptualized model for electrical brain stimulation</title>
		<author>
			<persName><forename type="first">Spezia</forename><surname>Adachi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">N</forename><surname>Quevedo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>De Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Scarabelot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">L</forename><surname>Rozisky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>De Oliveira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Marques</forename><surname>Filho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Medeiros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Fregni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Caumo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Torres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">L</forename></persName>
		</author>
		<idno type="DOI">10.1007/s00221-015-4212-1</idno>
		<ptr target="https://doi.org/10.1007/s00221-015-4212-1" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_Fz3tJ9E">Exp Brain Res</title>
		<imprint>
			<biblScope unit="volume">233</biblScope>
			<biblScope unit="page" from="1377" to="1389" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Spezia Adachi LN, Quevedo AS, de Souza A, Scarabelot VL, Rozisky JR, de Oliveira C, Marques Filho PR, Medeiros LF, Fregni F, Caumo W, Torres IL: Exogenously induced brain activation regulates neuronal activity by top-down modulation: conceptualized model for electrical brain stim- ulation. Exp Brain Res 233:1377-1389, 2015. https://doi.org/ 10.1007/s00221-015-4212-1</note>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main" xml:id="_nshZ399">Catastrophizing, depression and expectancies for pain and emotional distress</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Sullivan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Rodgers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Kirsch</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0304-3959(00)00430-9</idno>
		<ptr target="https://doi.org/10.1016/s0304-3959(00)00430-9" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_5PBmjrd">Pain</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="147" to="154" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sullivan MJ, Rodgers WM, Kirsch I: Catastrophizing, depression and expectancies for pain and emotional dis- tress. Pain 91:147-154, 2001. https://doi.org/10.1016/s0304- 3959(00)00430-9</note>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main" xml:id="_f2YqRev">Polarity specific effects of transcranial direct current stimulation on interhemispheric inhibition</title>
		<author>
			<persName><forename type="first">T</forename><surname>Tazoe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Endoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kitamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ogata</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0114244</idno>
		<ptr target="https://doi.org/10.1371/journal.pone.0114244" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_n5trDaD">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">114244</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tazoe T, Endoh T, Kitamura T, Ogata T: Polarity specific effects of transcranial direct current stimulation on inter- hemispheric inhibition. PLoS ONE 9:e114244, 2014. https:// doi.org/10.1371/journal.pone.0114244</note>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main" xml:id="_r6zwqsx">The effects of anodal-tDCS on corticospinal excitability enhancement and its after-effects: Conventional vs. unihemispheric concurrent dual-site stimulation</title>
		<author>
			<persName><forename type="first">B</forename><surname>Vaseghi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zoghi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jaberzadeh</surname></persName>
		</author>
		<idno type="DOI">10.3389/fnhum.2015.00533</idno>
		<ptr target="https://doi.org/10.3389/fnhum.2015.00533" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_zKCtSCw">Front Hum Neurosci</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">533</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Vaseghi B, Zoghi M, Jaberzadeh S: The effects of anodal-tDCS on corticospinal excitability enhancement and its after-effects: Conventional vs. unihemispheric concur- rent dual-site stimulation. Front Hum Neurosci 9:533, 2015. https://doi.org/10.3389/fnhum.2015.00533</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main" xml:id="_jWqkUtF">Association of anxiety with intracortical inhibition and descending pain modulation in chronic myofascial pain syndrome</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Vidor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">L</forename><surname>Torres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Medeiros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Duss An-Sarria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Dall'agnol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Deitos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Brietzke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Laste</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Rozisky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fregni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Caumo</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2202-15-42</idno>
		<ptr target="https://doi.org/10.1186/1471-2202-15-42" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_xcXnXJp">BMC Neurosci</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page">42</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Vidor LP, Torres IL, Medeiros LF, Duss an-Sarria JA, Dal- l&apos;agnol L, Deitos A, Brietzke A, Laste G, Rozisky JR, Fregni F, Caumo W: Association of anxiety with intracortical inhibi- tion and descending pain modulation in chronic myofascial pain syndrome. BMC Neurosci 15:42, 2014. https://doi.org/ 10.1186/1471-2202-15-42</note>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main" xml:id="_P6H2TWx">An fMRI-based neurologic signature of physical pain</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Wager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">Y</forename><surname>Atlas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Lindquist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Roy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kross</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmoa1204471</idno>
		<ptr target="https://doi.org/10.1056/NEJMoa1204471" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_SBHDTbH">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">368</biblScope>
			<biblScope unit="page" from="1388" to="1397" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wager TD, Atlas LY, Lindquist MA, Roy M, Woo CW, Kross E: An fMRI-based neurologic signature of physical pain. N Engl J Med 368:1388-1397, 2013. https://doi.org/ 10.1056/NEJMoa1204471</note>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main" xml:id="_d3XRP74">Effect of transcranial alternating current stimulation for the treatment of chronic insomnia: A randomized, double-blind, Parallel-Group, Placebo-Controlled Clinical Trial</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Xue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">C</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">T</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">L</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">X</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Dong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Q</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Q</forename><surname>Zhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">Q</forename><surname>Min</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Q</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">H</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Si</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">Y</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cosci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kamiya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">P</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.1159/000504609</idno>
		<ptr target="https://doi.org/10.1159/000504609" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_6EMvrpR">Psychother Psychosom</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="38" to="47" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wang HX, Wang L, Zhang WR, Xue Q, Peng M, Sun ZC, Li LP, Wang K, Yang XT, Jia Y, Zhou QL, Xu ZX, Li N, Dong K, Zhang Q, Song HQ, Zhan SQ, Min BQ, Fan CQ, Zhou AH, Guo XH, Li HB, Liang LR, Yin L, Si TM, Huang J, Yan TY, Cosci F, Kamiya A, Lu J, Wang YP: Effect of transcranial alternat- ing current stimulation for the treatment of chronic insom- nia: A randomized, double-blind, Parallel-Group, Placebo- Controlled Clinical Trial. Psychother Psychosom 89:38-47, 2020. https://doi.org/10.1159/000504609</note>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main" xml:id="_ceSwcGF">Role of central sensitization in symptoms beyond muscle pain, and the evaluation of a patient with widespread pain</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Yunus</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.berh.2007.03.006</idno>
		<ptr target="https://doi.org/10.1016/j.berh.2007.03.006" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_wSmtzwZ">Best Pract Res Clin Rheumatol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="481" to="497" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yunus MB: Role of central sensitization in symptoms beyond muscle pain, and the evaluation of a patient with widespread pain. Best Pract Res Clin Rheumatol 21:481-497, 2007. https://doi.org/10.1016/j.berh.2007.03.006</note>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main" xml:id="_zwwTtbp">Higher serum S100B and BDNF levels are correlated with a lower pressure-pain threshold in fibromyalgia</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Zanette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Dussan-Sarria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Deitos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">L</forename><surname>Torres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Caumo</surname></persName>
		</author>
		<idno type="DOI">10.1186/1744-8069-10-46</idno>
		<ptr target="https://doi.org/10.1186/1744-8069-10-46" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_9Hca6z9">Mol Pain</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">46</biblScope>
			<date type="published" when="2014-07-08">2014 Jul 8</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zanette SA, Dussan-Sarria JA, Souza A, Deitos A, Torres IL, Caumo W: Higher serum S100B and BDNF levels are cor- related with a lower pressure-pain threshold in fibromyal- gia. Mol Pain 10:46, 2014 Jul 8. https://doi.org/10.1186/ 1744-8069-10-46</note>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main" xml:id="_dAC2TtE">Transcranial direct current stimulation to improve the dysfunction of descending pain modulatory system related to opioids in chronic non-cancer pain: An integrative review of neurobiology and metaanalysis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Zortea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ramalho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Alves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cfds</forename><surname>Alves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Braulio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ilds</forename><surname>Torres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fregni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Caumo</surname></persName>
		</author>
		<idno type="DOI">10.3389/fnins.2019.01218</idno>
		<ptr target="https://doi.org/10.3389/fnins.2019.01218" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_MyEBfeg">Front Neurosci</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">1218</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zortea M, Ramalho L, Alves RL, Alves CFDS, Braulio G, Torres ILDS, Fregni F, Caumo W: Transcranial direct current stimulation to improve the dysfunction of descending pain modulatory system related to opioids in chronic non-cancer pain: An integrative review of neurobiology and meta- analysis. Front Neurosci 13:1218, 2019. https://doi.org/ 10.3389/fnins.2019.01218</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
